,drug_name,section_name,gpt_output
0,IMPAVIDO,adverse reactions,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, anemia, lymphadenopathy, abdominal distension, constipation, dysphagia, flatulence, fatigue, abscess, cellulitis, ecthyma, paresthesia, testicular pain, testicular swelling, urticaria, rash, pyoderma, agranulocytosis, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis"
1,IMPAVIDO,boxed warnings,"EMBRYO-FETAL TOXICITY, fetal harm, Fetal death, teratogenicity"
2,IMPAVIDO,warnings and precautions,"Embryo-Fetal Toxicity, testicular atrophy, impaired fertility in male rats, impaired fertility in female rats, serum creatinine elevations, transaminases elevations, bilirubin elevations, Gastrointestinal Effects, Thrombocytopenia, vomiting, diarrhea, Stevens-Johnson syndrome, scrotal pain, decreased or absent ejaculation, reversible follicular atresia, diestrus, reduced viable sperm counts, Elevations of serum creatinine, Elevations in liver transaminases (ALT, AST), volume depletion"
3,LIVALO,adverse reactions,"Rhabdomyolysis with myoglobinuria and acute renal failure, myopathy (including myositis), Liver Enzyme Abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions including rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, fatal and non-fatal hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment (e.g., memory loss, forgetfulness, amnesia, memory impairment, confusion), immune-mediated necrotizing myopathy"
4,LIVALO,warnings and precautions,"myopathy, rhabdomyolysis, acute renal failure secondary to myoglobinuria, liver enzyme abnormalities, persistent elevations in hepatic transaminases, immune-mediated necrotizing myopathy (IMNM), proximal muscle weakness, elevated serum creatine kinase, muscle biopsy showing necrotizing myopathy without significant inflammation, markedly elevated creatine kinase (CK) levels, unexplained muscle pain, tenderness, weakness, malaise, fever, increases in serum transaminases (aspartate aminotransferase [AST]/serum glutamic-oxaloacetic transaminase, alanine aminotransferase [ALT]/serum glutamic-pyruvic transaminase), fatal and non-fatal hepatic failure, serious liver injury with clinical symptoms and/or hyperbilirubinemia or jaundice, increases in HbA1c, fasting serum glucose levels"
5,XENAZINE,adverse reactions,"Depression and suicidality, Akathisia, restlessness, agitation, Parkinsonism, Dysphagia, Sedation and somnolence, Sedation/somnolence, fatigue, insomnia, depression, akathisia, anxiety, nausea, Sedation/somnolence, Insomnia, Depression, Anxiety/anxiety aggravated, Irritability, Decreased appetite, Obsessive reaction, Akathisia, Balance difficulty, Parkinsonism/bradykinesia, Dizziness, Dysarthria, Unsteady gait, Headache, Nausea, Vomiting, Fatigue, Fall, Laceration (head), Ecchymosis, Upper respiratory tract infection, Shortness of breath, Bronchitis, Dysuria, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash"
6,XENAZINE,boxed warnings,"depression, suicidal thoughts and behavior (suicidality), worsening of depression, unusual changes in behavior, prior suicide attempts or ideation"
7,XENAZINE,warnings and precautions,"worsening mood, cognition, rigidity, functional capacity, strong CYP2D6 inhibitor, Neuroleptic Malignant Syndrome (NMS), Restlessness, agitation, akathisia, parkinsonism, Dysphagia, aspiration pneumonia, Sedation/Somnolence, QTc prolongation, extrapyramidal disorders, depression, cognitive decline, parkinsonism, dysphagia, sedation/somnolence, akathisia, restlessness, disability, suicidal ideation, behaviors (suicidality), depression or worsening depression, suicide, attempted suicide, suicidal ideation, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, tachycardia, diaphoresis, cardiac dysrhythmia, elevated creatinine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, bradykinesia, hypertonia, esophageal dysmotility, postural dizziness, syncope, orthostasis, Dizziness, Hypotension, Orthostatic Hypotension, Hyperprolactinemia, amenorrhea, galactorrhea, gynecomastia, impotence, low levels of estrogen, increased risk of osteoporosis, Tardive Dyskinesia (TD), involuntary, dyskinetic movements, vacuous chewing, extrapyramidal symptoms, Binding to Melanin-Containing Tissues, toxicity in melanin-containing tissues, long-term ophthalmologic effects."
8,LINZESS,adverse reactions,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, fecal incontinence, dehydration, gastroesophageal reflux disease, vomiting, fatigue, upper respiratory tract infection, sinusitis, dyspepsia, rectal hemorrhage, hematochezia, melena, allergic reactions, urticaria, hives"
9,LINZESS,boxed warnings,deaths due to dehydration in young juvenile mice
10,LINZESS,warnings and precautions,"severe diarrhea, mortality within the first 24 hours due to dehydration, significant diarrhea, its potentially serious consequences"
11,OPSUMIT,adverse reactions,"Embryo-fetal Toxicity, Hepatotoxicity, Decrease in Hemoglobin, anemia, nasopharyngitis/pharyngitis, bronchitis, headache, influenza, urinary tract infection, hypersensitivity reactions (angioedema, pruritus and rash), nasal congestion"
12,OPSUMIT,boxed warnings,"EMBRYO-FETAL TOXICITY, fetal harm"
13,OPSUMIT,warnings and precautions,"hepatotoxicity, liver failure, baseline liver enzymes, monitor, Decreases in hemoglobin, Pulmonary edema, pulmonary veno-occlusive disease, discontinue treatment, Decreases in sperm count, fetal harm, embryo-fetal toxicity, elevated aminotransferases, liver enzyme tests, hepatic adverse events, symptoms suggesting hepatic injury, nausea, vomiting, right upper quadrant pain, fatigue, anorexia, jaundice, dark urine, fever, itching, clinically relevant aminotransferase elevations, increase in bilirubin, clinical symptoms of hepatotoxicity, Hemoglobin Decrease, hematocrit, mean decrease in hemoglobin, decrease in hemoglobin to below 10.0 g/dL, severe anemia, Pulmonary Edema with Pulmonary Veno-occlusive Disease (PVOD), Decreased Sperm Counts, adverse effects on spermatogenesis, effects on fertility"
14,ASCLERA,adverse reactions,"mild local reactions at the site of injection, Injection site haematoma, Injection site irritation, Injection site discoloration, Injection site pain, Injection site pruritus, Injection site warmth, Neovascularisation, Injection site thrombosis, Anaphylactic shock, angioedema, urticaria generalized, asthma, Cerebrovascular accident, migraine, paresthesia (local), loss of consciousness, confusional state, dizziness, Cardiac arrest, palpitations, Deep vein thrombosis, pulmonary embolism, syncope vasovagal, circulatory collapse, vasculitis, Dyspnea, Skin hyperpigmentation, dermatitis allergic, hypertrichosis, Injection site necrosis, pyrexia, hot flush, Nerve injury"
15,ASCLERA,warnings and precautions,"anaphylaxis, severe allergic reactions, anaphylactic reactions, tissue necrosis, severe necrosis, ischemia, gangrene, pain"
16,KYNAMRO,adverse reactions,"Risk of hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, treatment discontinuation, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, pain in extremity, musculoskeletal pain, insomnia, hypertension, neoplasms (benign and malignant), proteinuria, hypersensitivity reaction with angioedema, glomerular nephritis, platelet count decrease, transaminase elevations, erythema, pain, hematoma, pruritus, swelling, discoloration, recall reactions, myalgia, arthralgia, malaise, immunogenicity, anti-KYNAMRO antibodies, Idiopathic thrombocytopenic purpura"
17,KYNAMRO,boxed warnings,"elevations in transaminases, elevation in alanine aminotransferase (ALT) >= 3x upper limit of normal (ULN), increases hepatic fat, hepatic steatosis, risk factor for advanced liver disease, steatohepatitis, cirrhosis, clinically significant liver toxicity"
18,KYNAMRO,warnings and precautions,"erythema, pain, tenderness, pruritus, local swelling, influenza-like illness, pyrexia, chills, myalgia, arthralgia, malaise, fatigue, elevations in transaminases, hepatic steatosis, steatohepatitis, cirrhosis, nausea, vomiting, abdominal pain, fever, jaundice, lethargy, liver injury, increases in bilirubin >= 2x ULN, active liver disease"
19,XARELTO,adverse reactions,"Increased risk of stroke after discontinuation in nonvalvular atrial fibrillation, Bleeding risk, Spinal/epidural hematoma, bleeding, Hemorrhage, Major bleeding, Bleeding into a critical organ, Fatal bleeding, Bleeding resulting in transfusion of >=2 units of whole blood or packed red blood cells, Gastrointestinal bleeding, Intracranial, Non-fatal critical organ bleeding, Non-fatal non-critical organ bleeding, Decrease in Hb >= 2g/dL, Transfusion of >=2 units of whole blood or packed red blood cells, Clinically relevant non-major bleeding, Any bleeding, Menorrhagia, Major bleeding event, Extra-surgical site bleeding requiring transfusion of >2 units of whole blood or packed cells, Bleeding that required re-operation, Abdominal pain upper, Dyspepsia, Toothache, Fatigue, Sinusitis, Urinary tract infection, Back pain, Osteoarthritis, Oropharyngeal pain, Wound secretion, Pain in extremity, Muscle spasm, Syncope, Pruritus, Blister, pulmonary hemorrhage, pulmonary hemorrhage with bronchiectasis, agranulocytosis, thrombocytopenia, retroperitoneal hemorrhage, jaundice, cholestasis, hepatitis, hepatocellular injury, hypersensitivity, anaphylactic reaction, anaphylactic shock, angioedema, cerebral hemorrhage, subdural hematoma, epidural hematoma, hemiparesis, Stevens-Johnson syndrome"
20,XARELTO,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment"
21,XARELTO,warnings and precautions,"serious and fatal bleeding, obstetric hemorrhage, thrombotic events, stroke, blood loss, active pathological hemorrhage, bleeding, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, midline back pain, sensory and motor deficits, bowel and/or bladder dysfunction, spinal cord decompression, acute renal failure, coagulopathy, pregnancy-related hemorrhage, fetal distress"
22,CAPRELSA,adverse reactions,"QT Prolongation, Torsades de Pointes, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, diarrhea/colitis, rash, acneiform dermatitis, nausea, headache, upper respiratory tract infections, decreased appetite, abdominal pain, asthenia, fatigue, pyrexia, elevated creatinine, QT prolongation, hypertension, Diarrhea/Colitis, Nausea, Abdominal Pain, Vomiting, Dyspepsia, Dry Mouth, Rash, Dermatitis Acneiform/Acne, Dry Skin, Photosensitivity Reaction, Pruritus, Nail abnormalities, Alopecia, Hypertension/Hypertensive Crisis/Accelerated Hypertension, Headache, Dysgeusia, Fatigue, Upper Respiratory Tract Infections, Decreased Appetite, Hypocalcemia, ECG QT Prolonged, Corneal Abnormalities, Blurred Vision, Proteinuria, Depression, Muscle Spasms, pancreatitis, heart failure, intestinal perforation, Grade 1-2 bleeding events, Hypocalcemia, ALT Increased, Hypoglycemia, Creatinine Increased, Hypomagnesemia, Neutropenia, Thrombocytopenia"
23,CAPRELSA,boxed warnings,"QT prolongation, Torsades de pointes, sudden death, hypocalcemia, hypokalemia, hypomagnesemia"
24,CAPRELSA,warnings and precautions,"Prolonged QT Interval, Torsades de pointes, sudden death, Severe skin reactions, Stevens-Johnson syndrome, Interstitial lung disease (ILD), fatalities, Ischemic cerebrovascular events, hemorrhage, heart failure, diarrhea, hypertension, reversible posterior leukoencephalopathy syndrome, Embryofetal toxicity, Photosensitivity reactions, pneumonitis, Serious hemorrhagic events, hemoptysis, Hypothyroidism, hypertensive crisis, Reversible posterior leukoencephalopathy syndrome (RPLS), seizures, headache, visual disturbances, confusion, altered mental function, ventricular tachycardia, bradyarrhythmias, uncompensated heart failure, electrolyte imbalance, hypothyroidism, embryotoxic, fetotoxic, teratogenic, adverse effects on female fertility, embryofetal development, postnatal development of pups"
25,KADCYLA,adverse reactions,"Hepatotoxicity, Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Pulmonary Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Hemorrhage, Thrombocytopenia, Neurotoxicity, fatigue, nausea, musculoskeletal pain, headache, increased transaminases, constipation, epistaxis, Neutropenia, Anemia, Lacrimation increased, Dry eye, Vision blurred, Conjunctivitis, Dyspepsia, Stomatitis, Dry Mouth, Abdominal pain, Vomiting, Diarrhea, Peripheral edema, Chills, Pyrexia, Asthenia, Nodular regenerative hyperplasia, Portal hypertension, Drug hypersensitivity, Infusion-related reaction, Urinary tract infection, Blood alkaline phosphatase increased, Hypokalemia, Myalgia, Arthralgia, Dysgeusia, Dizziness, Peripheral neuropathy, Insomnia, Pneumonitis, Dyspnea, Cough, Pruritus, Rash, Hypertension, Increased bilirubin, Increased AST, Increased ALT, Decreased platelet count, Decreased hemoglobin, Decreased neutrophils, Decreased potassium, Hepatic failure, anti-therapeutic antibody (ATA) responses to KADCYLA."
26,KADCYLA,boxed warnings,"hepatotoxicity, liver failure, death, increased serum transaminases, total bilirubin, reductions in left ventricular ejection fraction, clinically significant decrease in left ventricular function, embryo-fetal death, birth defects"
27,KADCYLA,warnings and precautions,"interstitial lung disease, pneumonitis, infusion-related reactions, hypersensitivity reactions, hemorrhage, thrombocytopenia, neurotoxicity, hepatotoxicity, severe drug-induced liver injury, hepatic encephalopathy, nodular regenerative hyperplasia, non-cirrhotic portal hypertension, left ventricular dysfunction, embryo-fetal toxicity, oligohydramnios, pulmonary hypoplasia, skeletal abnormalities, neonatal death, acute respiratory distress syndrome, fatal outcome, dyspnea, cough, fatigue, pulmonary infiltrates, flushing, chills, pyrexia, hypotension, wheezing, bronchospasm, tachycardia, allergic/anaphylactic-like reaction, central nervous system hemorrhage, respiratory hemorrhage, gastrointestinal hemorrhage, decreased platelet count, peripheral neuropathy, extravasation, erythema, tenderness, skin irritation, pain, swelling at the infusion site"
28,RELISTOR,adverse reactions,"Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarctions (1 fatal), Stroke (fatal), Fatal cardiac arrest, Sudden death, Cramping, Perforation, Vomiting, Diaphoresis, Flushing, Malaise, Pain"
29,RELISTOR,warnings and precautions,"Gastrointestinal perforation, severe, persistent or worsening abdominal pain, Severe or persistent diarrhea, Opioid withdrawal, hyperhidrosis, chills, diarrhea, abdominal pain, anxiety, yawning"
30,JUXTAPID,adverse reactions,"hepatotoxicity, Reduced absorption of fat-soluble vitamins, serum fatty acids, Gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, abdominal pain, nausea, gastroenteritis, weight loss, headache, difficulty controlling INR on warfarin, weight loss, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, Gastrointestinal Disorders, Diarrhea, Nausea, Dyspepsia, Vomiting, Abdominal pain, Abdominal discomfort, Abdominal distension, Constipation, Flatulence, Gastroesophageal reflux disease, Defecation urgency, Rectal tenesmus, Infections, Influenza, Nasopharyngitis, Gastroenteritis, Investigations, Decreased weight, Increased ALT, General Disorders, Chest pain, Fatigue, Fever, Musculoskeletal Disorders, Back pain, Nervous System Disorders, Headache, Dizziness, Respiratory Disorders, Pharyngolaryngeal pain, Nasal congestion, Cardiac Disorders, Angina pectoris, Palpitations, severe intensity, increased ALT, hepatotoxicity, abdominal pain, distension, discomfort, Transaminase Elevations, Hepatic Steatosis, hepatic fat accumulation, histological sequelae."
31,JUXTAPID,boxed warnings,"elevations in transaminases, elevation in alanine aminotransferase (ALT), elevation in aspartate aminotransferase (AST), hepatic fat increase, hepatic steatosis, progressive liver disease, steatohepatitis, cirrhosis, clinically significant liver toxicity"
32,JUXTAPID,warnings and precautions,"Embryo-Fetal Toxicity, Gastrointestinal adverse reactions, elevations in transaminases, hepatic steatosis, elevations in bilirubin, increases in INR, steatohepatitis, cirrhosis, hepatic dysfunction, hepatic failure, nausea, vomiting, abdominal pain, fever, jaundice, lethargy, flu-like symptoms, diarrhea, dyspepsia, abdominal discomfort, abdominal distension, constipation, flatulence, liver injury, hepatotoxicity, reduced absorption of fat-soluble vitamins, serum fatty acids, vitamin E deficiency, linoleic acid deficiency, alpha-linolenic acid (ALA) deficiency, eicosapentaenoic acid (EPA) deficiency, docosahexaenoic acid (DHA) deficiency, arachidonic acid deficiency, malabsorption, myopathy, rhabdomyolysis, supratherapeutic anticoagulation, subtherapeutic anticoagulation, malabsorption with rare hereditary disorders of galactose intolerance."
33,SAVELLA,adverse reactions,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, upper respiratory tract infection, blood pressure increased, decreased appetite, migraine, paresthesia, tremor, hypoesthesia, tension headache, anxiety, dyspnea, rash, pruritus, flushing, weight loss, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis"
34,SAVELLA,boxed warnings,"suicidal thinking, behavior (suicidality), clinical worsening, unusual changes in behavior"
35,SAVELLA,warnings and precautions,"suicidality, worsening of depressive symptoms, suicide risk, Serotonin Syndrome, Elevated blood pressure, heart rate elevations, Seizures, Hepatotoxicity, ALT and AST elevations, fulminant hepatitis, Withdrawal symptoms, Abnormal Bleeding, genitourinary adverse events, worsening of their depression, emergence of suicidal ideation and behavior, suicidality, unusual changes in behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), hypertensive blood pressure measurement, sustained increases in blood pressure, treatment-emergent blood pressure elevations, new onset hypertension, sustained increases in SBP, sustained increases in DBP, elevated blood pressure requiring immediate treatment, mean increases in heart rate, increases in heart rate >= 20 beats per minute, seizures/convulsions, mild elevations of ALT or AST, increases of bilirubin, jaundice, other evidence of liver dysfunction, dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, Hyponatremia, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, bleeding events, ecchymoses, hematomas, epistaxis, petechiae, life-threatening hemorrhages, activation of mania, hypomania, dysuria, urinary retention, testicular pain, ejaculation disorders, angle closure attack, elevated transaminases."
36,SAMSCA,adverse reactions,"thirst, dry mouth, asthenia, constipation, pollakiuria or polyuria, hyperglycemia, pyrexia, anorexia, mortality, nausea, gastrointestinal bleeding, disseminated intravascular coagulation, intracardiac thrombus, ventricular fibrillation, prothrombin time prolonged, ischemic colitis, diabetic ketoacidosis, rhabdomyolysis, cerebrovascular accident, urethral hemorrhage, vaginal hemorrhage, pulmonary embolism, respiratory failure, deep vein thrombosis, osmotic demyelination syndrome, hypernatremia, hypersensitivity reactions including anaphylactic shock and rash generalized"
37,SAMSCA,boxed warnings,"osmotic demyelination, dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, death"
38,SAMSCA,warnings and precautions,"Liver injury, Dehydration, Hypovolemia, Osmotic demyelination syndrome, Dysarthria, Mutism, Dysphagia, Lethargy, Affective changes, Spastic quadriparesis, Seizures, Coma, Death, Increased ALT, Fatigue, Anorexia, Right upper abdominal discomfort, Dark urine, Jaundice, Hyperkalemia"
39,JETREA,adverse reactions,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, Dyschromatopsia"
40,JETREA,warnings and precautions,"decreases in vision, progression of the condition with traction, surgical intervention, intraocular inflammation, intraocular infection, intraocular hemorrhage, increased IOP, lens subluxation, retinal detachment, retinal tear, Dyschromatopsia, yellowish vision, electroretinographic (ERG) changes, a- and b-wave amplitude decrease"
41,OPDIVO,adverse reactions,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis and Renal Dysfunction, Immune-Mediated Hypothyroidism and Hyperthyroidism, Other Immune-Mediated Adverse Reactions, rash, fatigue, dyspnea, musculoskeletal pain, decreased appetite, cough, nausea, constipation, abdominal pain, hyponatremia, increased aspartate aminotransferase, increased lipase, pruritus, upper respiratory tract infection, peripheral edema, ventricular arrhythmia, iridocyclitis, infusion-related reactions, increased amylase, dizziness, peripheral and sensory neuropathy, exfoliative dermatitis, erythema multiforme, vitiligo, psoriasis, increased AST, increased alkaline phosphatase, hyperkalemia, increased ALT, asthenia, pyrexia, chest pain, pain, arthralgia, vomiting, diarrhea, decreased weight, pneumonia, stomatitis, peripheral neuropathy, bronchitis, lymphopenia, anemia, thrombocytopenia, increased creatinine, hypercalcemia, hypokalemia, hypomagnesemia, hypocalcemia."
42,OPDIVO,warnings and precautions,"immune-mediated pneumonitis, severe pneumonitis, interstitial lung disease, fatal immune-mediated pneumonitis, fatal pneumonitis, Grade 3 pneumonitis, Grade 2 pneumonitis, immune-mediated colitis, diarrhea, colitis, Grade 3 colitis, Grade 2 colitis, immune-mediated hepatitis, liver test abnormalities, increases in AST, alkaline phosphatase, ALT, total bilirubin, Grade 3 hepatitis, Grade 2 hepatitis, immune-mediated nephritis, renal dysfunction, elevated creatinine, Grade 2 or 3 immune-mediated nephritis, Grade 2 or 3 renal dysfunction, immune-mediated hypothyroidism, hypothyroidism, Grade 1 or 2 hypothyroidism, hyperthyroidism, Grade 1 or 2 hyperthyroidism, Grade 2 hyperthyroidism, adrenal insufficiency, uveitis, pancreatitis, facial nerve paresis, abducens nerve paresis, demyelination, autoimmune neuropathy, motor dysfunction, vasculitis, hypophysitis, diabetic ketoacidosis, hypopituitarism, Guillain-Barre syndrome, myasthenic syndrome, embryofetal toxicity, increased abortion, premature infant death"
43,VICTOZA,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, headache, nausea, diarrhea, anti-liraglutide antibody formation, Immunogenicity-related events, urticaria, upper respiratory tract infections, gastrointestinal events, injection site reactions, injection site rash, erythema, papillary thyroid carcinoma, malignant neoplasms, mildly elevated serum bilirubin concentrations, elevated serum calcitonin, increased heart rate, Medullary thyroid carcinoma, Dehydration, Increased serum creatinine, acute renal failure, worsening of chronic renal failure, Angioedema, anaphylactic reactions, Allergic reactions, rash, pruritus, Acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, vomiting, dyspepsia, constipation, cross-reacting anti-liraglutide antibodies, antibodies with neutralizing effect on liraglutide, infections, nonserious upper respiratory tract infections, withdrawal due to gastrointestinal adverse events, withdrawal due to nausea, withdrawal due to vomiting"
44,VICTOZA,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
45,VICTOZA,warnings and precautions,"Thyroid C-cell tumors, fatal and non-fatal hemorrhagic or necrotizing pancreatitis, serious hypoglycemia, renal impairment, serious hypersensitivity reactions, anaphylactic reactions, angioedema, acute pancreatitis, persistent severe abdominal pain, vomiting, chronic pancreatitis, necrosis, cholelithiasis, alcohol abuse, hypoglycemia, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration."
46,EFFIENT,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, Thrombotic thrombocytopenic purpura, TIMI Major or Minor bleeding, TIMI Major bleeding, Symptomatic intracranial hemorrhage (ICH), Requiring inotropes, Requiring surgical intervention, Requiring transfusion (>=4 units), TIMI Minor bleeding, CABG-related TIMI Major or Minor bleeding, Fatal, Reoperation, Transfusion of >=5 units, Intracranial hemorrhage, epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade, retinal hemorrhage, severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, Thrombocytopenia, Hypersensitivity reactions including anaphylaxis"
47,EFFIENT,boxed warnings,"significant bleeding, fatal bleeding, active pathological bleeding, intracranial bleeding, hypotensive, propensity to bleed, increase the risk of bleeding, suspect bleeding, manage bleeding without discontinuing Effient, stopping Effient increases the risk of subsequent cardiovascular events"
48,EFFIENT,warnings and precautions,"CABG-related bleeding, stent thrombosis, MI, death, Thrombotic thrombocytopenic purpura (TTP), Hypersensitivity, angioedema, bleeding, TIMI Major bleeding, TIMI Minor bleeding, hypotensive, active bleeding, TIA, stroke, fatal bleeding, recent trauma, recent surgery, recent or recurrent gastrointestinal (GI) bleeding, active peptic ulcer disease, severe hepatic impairment, moderate to severe renal impairment, hemorrhage, hemostasis, transfusion of blood products, packed red blood cells, platelets, microangiopathic hemolytic anemia, neurological findings, renal dysfunction, fever"
49,ENTYVIO,adverse reactions,"Infusion-Related Reactions and Hypersensitivity Reactions, Infections, Progressive Multifocal Leukoencephalopathy, Liver Injury, nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, pain in extremities, anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, increased blood pressure and heart rate, dizziness, vomiting, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, bacterial sepsis, septic shock, latent pulmonary tuberculosis, hepatitis, malignancies, colon cancer, transitional cell carcinoma, breast cancer, carcinoid tumor of the appendix, squamous cell carcinoma, B-cell lymphoma, malignant hepatic neoplasm, malignant lung neoplasm, malignant melanoma, lung cancer of primary neuroendocrine carcinoma, renal cancer, lower seroconversion rates and anti-cholera titers, immunogenicity, anti-vedolizumab antibody, neutralizing antibodies to vedolizumab."
50,ENTYVIO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, serious allergic reactions, dyspnea, bronchospasm, urticaria, flushing, rash, increased blood pressure, increased heart rate, infections, nasopharyngitis, upper respiratory tract infection, anal abscess, sepsis, fatal sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, progressive multifocal leukoencephalopathy (PML), death, neurological signs or symptoms, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory changes, orientation changes, confusion, personality changes, severe disability, liver injury, elevations of transaminase, elevations of bilirubin, severe liver injury, jaundice, significant liver injury"
51,ADEMPAS,adverse reactions,"Embryo-Fetal Toxicity, Hypotension, Bleeding, headache, dyspepsia/gastritis, dizziness, nausea, diarrhea, hypotension, vomiting, anemia, gastroesophageal reflux, constipation, palpitations, nasal congestion, epistaxis, dysphagia, abdominal distension, peripheral edema"
52,ADEMPAS,boxed warnings,fetal harm
53,ADEMPAS,warnings and precautions,"Symptomatic hypotension, Bleeding, Pulmonary edema, Fetal harm, Serious bleeding, Serious hemoptysis, Fatal outcome, Vaginal hemorrhage, Catheter site hemorrhage, Subdural hematoma, Hematemesis, Intra-abdominal hemorrhage, Worsening cardiovascular status, Discontinue treatment"
54,MOVANTIK,adverse reactions,"Gastrointestinal perforation, Opioid withdrawal, abdominal pain, diarrhea, nausea, flatulence, vomiting, headache, hyperhidrosis, chills, anxiety, irritability, yawning"
55,MOVANTIK,warnings and precautions,"Gastrointestinal perforation, severe, persistent or worsening abdominal pain, opioid withdrawal, hyperhidrosis, chills, diarrhea, abdominal pain, anxiety, irritability, yawning, gastrointestinal adverse reactions"
56,STIVARGA,adverse reactions,"Hepatotoxicity, Hemorrhage, Dermatological Toxicity, Hypertension, Cardiac Ischemia and Infarction, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Gastrointestinal Perforation or Fistula, asthenia/fatigue, HFSR, diarrhea, decreased appetite/food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal and abdominal pain, rash, fever, nausea, Hand-foot skin reaction (HFSR), Anemia, Thrombocytopenia, Neutropenia, Lymphopenia, Hypocalcemia, Hypokalemia, Hyponatremia, Hypophosphatemia, Hyperbilirubinemia, Increased AST, Increased ALT, Proteinuria, Increased INR, Increased Lipase, Increased Amylase, Alopecia, Hypothyroidism, Musculoskeletal stiffness, hypersensitivity reaction"
57,STIVARGA,boxed warnings,"Severe hepatotoxicity, fatal hepatotoxicity, elevated liver function tests, hepatocellular necrosis"
58,STIVARGA,warnings and precautions,"severe or life-threatening hemorrhage, Dermatological toxicity, severe or uncontrolled hypertension, new or acute cardiac ischemia/infarction, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Gastrointestinal perforation or fistulae, wound healing complications, Embryofetal toxicity, Severe drug induced liver injury with fatal outcome, hepatocyte necrosis with lymphocyte infiltration, fatal hepatic failure, elevated liver function tests, hepatocellular necrosis, increased incidence of hemorrhage, Fatal hemorrhage, respiratory hemorrhage, gastrointestinal hemorrhage, genitourinary hemorrhage, hand-foot skin reaction (HFSR), palmar-plantar erythrodysesthesia (PPE), severe rash requiring dose modification, Grade 3 HFSR, Grade 3 rash, serious adverse reactions of erythema multiforme, Stevens Johnson Syndrome, Toxic epidermal necrolysis, increased incidence of hypertension, Hypertensive crisis, myocardial ischemia and infarction, subcortical vasogenic edema, seizures, headache, visual disturbances, confusion, altered mental function, gastrointestinal fistula, wound dehiscence, embryolethal, teratogenic, cardiovascular malformations, genitourinary malformations, skeletal malformations"
59,ANORO,adverse reactions,"asthma-related death, Paradoxical bronchospasm, Cardiovascular effects, Worsening of narrow-angle glaucoma, Worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough, dry mouth, dyspepsia, abdominal pain, gastroesophageal reflux disease, vomiting, musculoskeletal chest pain, chest discomfort, asthenia, atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, pruritus, rash, conjunctivitis, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus"
60,ANORO,boxed warnings,asthma-related death
61,ANORO,warnings and precautions,"asthma-related death, paradoxical bronchospasm, cardiovascular disorders, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, narrow-angle glaucoma, urinary retention, hypokalemia, hyperglycemia, clinically significant cardiovascular effects, fatalities, hypersensitivity reactions, anaphylactic reactions, increases in pulse rate, systolic or diastolic blood pressure, electrocardiographic changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, eye pain or discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination"
62,VIMPAT,adverse reactions,"Suicidal Behavior and Ideation, Dizziness and Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, diplopia, headache, dizziness, nausea, insomnia, dizziness, headache, nausea, somnolence, fatigue, ataxia, vomiting, diplopia, vertigo, blurred vision, Vertigo, Diplopia, Blurred Vision, Nausea, Vomiting, Diarrhea, Fatigue, Gait disturbance, Asthenia, Contusion, Skin laceration, Dizziness, Headache, Ataxia, Somnolence, Tremor, Nystagmus, Balance disorder, Memory impairment, Depression, Pruritus, liver function tests abnormalities, ALT elevations, hepatitis, nephritis, neutropenia, anemia, palpitations, tinnitus, constipation, dyspepsia, dry mouth, oral hypoaesthesia, irritability, pyrexia, feeling drunk, fall, muscle spasms, paresthesia, cognitive disorder, hypoaesthesia, dysarthria, disturbance in attention, cerebellar syndrome, confusional state, mood altered, depressed mood, injection site pain or discomfort, irritation, erythema, profound bradycardia, Dry mouth, Oral Paresthesia, Oral Hypoesthesia, Chest pain, Abnormal Coordination, Hyperhidrosis, Agranulocytosis, Aggression, agitation, hallucination, psychotic disorder, Angioedema, rash, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis."
63,VIMPAT,warnings and precautions,"suicidal behavior and ideation, dizziness, ataxia, Cardiac Rhythm and Conduction Abnormalities, syncope, increased seizure frequency, Multiorgan Hypersensitivity Reactions, PR interval prolongation, first-degree atrioventricular (AV) block, second degree AV block, complete AV block, profound bradycardia, third degree AV block, Atrial fibrillation, Atrial flutter, loss of consciousness, symptomatic hepatitis, nephritis, rash, elevated liver enzymes, myocarditis, fever, eosinophilia, lymphadenopathy, phenylalanine"
64,BANZEL,adverse reactions,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, influenza, nasopharyngitis, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, anemia, lymphadenopathy, leukopenia, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, decreased appetite, increased appetite, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence, Stevens-Johnson syndrome"
65,BANZEL,warnings and precautions,"new or worsening depression, suicidal thoughts/behavior, unusual changes in mood or behavior, Central nervous system reactions, multi-organ hypersensitivity reaction, precipitating seizures, seizure exacerbation, status epilepticus, suicidal thoughts or behavior, depression, somnolence, fatigue, coordination abnormalities, dizziness, gait disturbances, ataxia, study discontinuation, QT shortening, sudden death, ventricular arrhythmias, ventricular fibrillation, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, Leukopenia"
66,XELJANZ,adverse reactions,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, infections, urinary tract infections, pneumonia, cellulitis, herpes zoster, urinary tract infection, tuberculosis, opportunistic infections, malignancies excluding NMSC, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, lymphoma, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, ALT elevations, AST elevations, drug-induced liver injury, lipid elevations, LDL cholesterol increase, HDL cholesterol increase, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema"
67,XELJANZ,boxed warnings,"serious infections leading to hospitalization, death, tuberculosis, bacterial infections, invasive fungal infections, viral infections, other opportunistic infections, lymphoma, malignancies, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, active tuberculosis, pulmonary disease, extrapulmonary disease, cryptococcosis, pneumocystosis, disseminated disease, localized disease"
68,XELJANZ,warnings and precautions,"serious infections, bacterial infections, mycobacterial infections, invasive fungal infections, viral infections, opportunistic infections, pneumonia, cellulitis, herpes zoster, urinary tract infection, diverticulitis, tuberculosis, cryptococcosis, esophageal candidiasis, pneumocystosis, multidermatomal herpes zoster, cytomegalovirus, BK virus, sepsis, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, malignancies, solid cancers, lymphoma, non-melanoma skin cancers, gastrointestinal perforation, lymphocytosis, lymphocyte abnormalities, neutropenia, anemia, liver enzyme elevations, lipid elevations, increased total cholesterol, increased low-density lipoprotein cholesterol, increased high-density lipoprotein cholesterol"
69,GATTEX,adverse reactions,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, congestive heart failure, cognition and attention disturbances, immunogenicity, anti-GATTEX antibody, neutralizing antibodies"
70,GATTEX,warnings and precautions,"acceleration of neoplastic growth, intestinal obstruction, biliary and pancreatic disease, fluid overload, colorectal polyps, small bowel neoplasia, cholecystitis, cholangitis, cholelithiasis, pancreatitis, congestive heart failure, altered mental status"
71,XOFIGO,adverse reactions,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, Pancytopenia, Renal failure and impairment, Dehydration, Erythema, pain, edema at the injection site, Secondary Malignant Neoplasms, osteosarcoma"
72,XOFIGO,warnings and precautions,"bone marrow suppression, bone marrow failure, ongoing pancytopenia, deaths due to bone marrow failure, bone marrow failure was ongoing at the time of death, required blood transfusions, permanently discontinued therapy due to bone marrow suppression, deaths related to vascular hemorrhage, myelosuppression, thrombocytopenia, neutropenia, pancytopenia, leukopenia, serious infections, febrile neutropenia, additive myelosuppression"
73,SYNRIBO,adverse reactions,"Myelosuppression, Bleeding, Hyperglycemia, thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, Blood and Lymphatic System Disorders, Bone Marrow Failure, Febrile Neutropenia, Gastrointestinal Disorders, Constipation, Abdominal Pain/Upper Abdominal Pain, Vomiting, General Disorders and Administration Site Conditions, Edema Peripheral, Infusion and injection site related reactions, Infections and Infestations, Metabolism and Nutrition Disorders, Anorexia, Musculoskeletal and Connective Tissue Disorders, Arthralgia, Pain in Extremity, Back Pain, Myalgia, Nervous System Disorders, Headache, Psychiatric Disorders, Insomnia, Respiratory, Thoracic and Mediastinal Disorders, Cough, Epistaxis, Skin and Subcutaneous Tissue Disorders, Alopecia, Rash, bone marrow failure, cerebral hemorrhage, multi-organ failure, progression of disease, leukocytosis, Chills, Dyspnea, Laboratory Abnormalities, Hemoglobin Decreased, Leukocytes Decreased, Neutrophils Decreased, Platelets Decreased, Biochemistry Parameters, Alanine aminotransferase (ALT) Increased, Bilirubin Increased, Creatinine Increased, Glucose Increased, Uric Acid Increased, Glucose Decreased, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, Ear and Labyrinth Disorders, ear pain, ear hemorrhage, tinnitus, Eye Disorders, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, cerebral hemorrhage, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension."
74,SYNRIBO,warnings and precautions,"severe and fatal thrombocytopenia, neutropenia, anemia, increased risk of hemorrhage, Fatal cerebral hemorrhage, severe non-fatal gastrointestinal hemorrhage, glucose intolerance, hyperglycemia, hyperosmolar non-ketotic hyperglycemia, embryo-fetal toxicity, fetal harm, fatalities related to myelosuppression, increased risk for infections, Grade 3 or 4 thrombocytopenia, Grade 3 or 4 neutropenia, Grade 3 or 4 anemia, Grade 3 or 4 hyperglycemia, embryo-fetal death in animals"
75,ICLUSIG,adverse reactions,"Vascular Occlusion, Heart Failure, Hepatotoxicity, Hypertension, Pancreatitis, Neuropathy, Ocular Toxicity, Hemorrhage, Fluid Retention, Cardiac Arrhythmias, Myelosuppression, arterial ischemia, cardiac failure, peripheral neuropathy, thrombocytopenia, infections, neutropenia, lipase increased, rash, abdominal pain, pancreatitis, ALT increased, AST increased, GGT increased, Hypertension, Arterial ischemia, Cardiac Failure, Abdominal pain, Constipation, Nausea, Diarrhea, Vomiting, Oral mucositis, GI hemorrhage, Febrile neutropenia, Sepsis, Pneumonia, Urinary tract infection, Upper respiratory tract infection, Nasopharyngitis, Cellulitis, Headache, Peripheral neuropathy, Dizziness, Pleural effusion, Cough, Dyspnea, Rash and related conditions, Dry skin, Arthralgia, Myalgia, Pain in extremity, Back pain, Muscle spasms, Bone pain, Fatigue or asthenia, Pyrexia, Edema, peripheral, Pain, Chills, Decreased appetite, Weight decreased, Insomnia, Arterial ischemic event, Cardiovascular, Cerebrovascular, Peripheral vascular, CNS hemorrhage, Gastrointestinal hemorrhage, Effusions, Atrial fibrillation, Venous thromboembolism, Pancreatitis, Thrombocytopenia, Anemia, Lymphopenia, Leukopenia, ALT increased, AST increased, Alkaline phosphatase increased, Albumin decreased, Bilirubin increased, Lipase increased, Amylase increased, Glucose increased, Phosphorus decreased, Calcium decreased, Sodium decreased, Glucose decreased, Potassium decreased, Potassium increased, Sodium increased, Bicarbonate decreased, Creatinine increased, Calcium increased, Triglycerides increased."
76,ICLUSIG,boxed warnings,"arterial thrombosis, venous thrombosis, occlusions, fatal myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, urgent revascularization procedures, heart failure, fatalities, hepatotoxicity, liver failure, death"
77,ICLUSIG,warnings and precautions,"hypertension, high blood pressure, pancreatitis, serum lipase increased, neuropathy, peripheral neuropathy, cranial neuropathy, ocular toxicity, comprehensive eye exams, hemorrhage, serious hemorrhage, severe hemorrhage, fluid retention, cardiac arrhythmias, arrhythmias, myelosuppression, thrombocytopenia, neutropenia, anemia, tumor lysis syndrome, compromised wound healing, gastrointestinal perforation, embryo-fetal toxicity, fetal harm, vascular occlusion, arterial thrombosis, venous thrombosis, occlusions, myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, urgent revascularization procedures, recurrent vascular occlusion, multi-site vascular occlusion, arterial occlusion, thrombosis, cardiac vascular occlusion, coronary artery occlusion, heart failure, left ventricular dysfunction, cerebrovascular occlusion, peripheral arterial occlusive events, mesenteric artery occlusion, peripheral arterial disease, digital necrosis, distal extremity necrosis, amputations, venous thromboembolism, deep venous thrombosis, pulmonary embolism, superficial thrombophlebitis, retinal vein thrombosis, hepatotoxicity, liver failure, death, fulminant hepatic failure, severe hepatotoxicity, aspartate aminotransferase elevation, alanine aminotransferase elevation, symptomatic hypertension, hypertensive crisis, Stage 1 hypertension, Stage 2 hypertension, pancreatitis, lipase elevation, abdominal symptoms, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, blindness, blurred vision, retinal toxicities, macular edema, retinal vein occlusion, retinal hemorrhage, conjunctival irritation, corneal irritation, dry eye, eye pain, cataracts, glaucoma, iritis, iridocyclitis, ulcerative keratitis, cerebral hemorrhage, gastrointestinal hemorrhage, brain edema, pericardial effusion, pleural effusion, ascites, peripheral edema, symptomatic bradyarrhythmias, pacemaker implantation, complete heart block, sick sinus syndrome, atrial fibrillation with bradycardia and pauses, supraventricular tachyarrhythmias, atrial flutter, supraventricular tachycardia, atrial tachycardia, tumor lysis syndrome, hyperuricemia, gastrointestinal perforation (fistula), embryo-fetal toxicity."
78,SABRIL,adverse reactions,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence and Fatigue, Peripheral Neuropathy, Weight Gain, Edema, fatigue, somnolence, nystagmus, tremor, vision blurred, memory impairment, arthralgia, abnormal coordination, confusional state, increased weight, upper respiratory tract infection, aggression, diplopia, bronchitis, ear infection, otitis media acute, headache, dizziness, convulsion, nasopharyngitis, visual field defect, depression, nausea, diarrhea, insomnia, irritability, coordination abnormal, vomiting, influenza, pyrexia, rash, tinnitus, vertigo, asthenopia, eye pain, diarrhoea, constipation, abdominal pain upper, dyspepsia, stomach discomfort, abdominal pain, toothache, abdominal distension, gait disturbance, asthenia, oedema peripheral, fever, chest pain, thirst, malaise, urinary tract infection, contusion, joint sprain, muscle strain, wound secretion, increased appetite, back pain, pain in extremity, myalgia, muscle twitching, muscle spasms, somnolence, disturbance in attention, sensory disturbance, hyporeflexia, paraesthesia, lethargy, hyperreflexia, hypoaesthesia, sedation, status epilepticus, dysarthria, postictal state, sensory loss, irritability, anxiety, depressed mood, thinking abnormal, abnormal behaviour, expressive language disorder, nervousness, abnormal dreams, dysmenorrhoea, erectile dysfunction, pharyngolaryngeal pain, cough, pulmonary congestion, sinus headache, strabismus, conjunctivitis, viral infection, pneumonia, candidiasis, gastroenteritis viral, sinusitis, croup infectious, decreased appetite, sedation, status epilepticus, lethargy, convulsion, hypotonia, irritability, insomnia, nasal congestion, cough, rash, congenital cardiac defects, congenital external ear anomaly, congenital hemangioma, congenital hydronephrosis, congenital male genital malformation, congenital oral malformation, congenital vesicoureteric reflux, dentofacial anomaly, dysmorphism, fetal anticonvulsant syndrome, hamartomas, hip dysplasia, limb malformation, limb reduction defect, low set ears, renal aplasia, retinitis pigmentosa, supernumerary nipple, talipes, deafness, delayed puberty, gastrointestinal hemorrhage, esophagitis, developmental delay, facial edema, malignant hyperthermia, multi-organ failure, cholestasis, dystonia, encephalopathy, hypertonia, muscle spasticity, myoclonus, optic neuritis, dyskinesia, acute psychosis, apathy, delirium, hypomania, neonatal agitation, psychotic disorder, laryngeal edema, pulmonary embolism, respiratory failure, stridor, angioedema, maculo-papular rash, pruritus, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
79,SABRIL,boxed warnings,"permanent bilateral concentric visual field constriction, ranging in severity from mild to severe, tunnel vision to within 10 degrees of visual fixation, damage the central retina, decrease visual acuity, vision loss, severe vision loss, vision loss of milder severity, irreversible vision loss, retinopathy, glaucoma, progressive and permanent bilateral concentric visual field constriction, reduce visual acuity, new and worsening vision loss"
80,SABRIL,warnings and precautions,"Permanent vision loss, Abnormal MRI signal changes, Suicidal behavior and ideation, Withdrawal seizures, Anemia, Somnolence and fatigue, Peripheral Neuropathy, Weight Gain, Edema"
81,VPRIV,adverse reactions,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue/asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension"
82,VPRIV,warnings and precautions,"hypersensitivity reactions, anaphylaxis, headache, dizziness, hypotension, hypertension, nausea, fatigue, asthenia, pyrexia, body temperature increased, chest discomfort, dyspnea, pruritus"
83,DALIRESP,adverse reactions,"Psychiatric Events Including Suicidality, Weight Decrease, diarrhea, nausea, headache, back pain, influenza, insomnia, dizziness, decreased appetite, atrial fibrillation, lung cancer, prostate cancer, acute pancreatitis, acute renal failure, abdominal pain, dyspepsia, gastritis, vomiting, rhinitis, sinusitis, urinary tract infection, muscle spasms, tremor, anxiety, depression, hypersensitivity reactions including angioedema, urticaria, rash"
84,DALIRESP,warnings and precautions,"acute bronchospasm, insomnia, anxiety, depression, suicidal thoughts, psychiatric adverse reactions, weight loss, moderate weight loss, severe weight loss, suicide-related adverse reactions, completed suicide, suicide attempts, suicidal ideation"
85,SYLVANT,adverse reactions,"Concurrent active severe infections, Infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash (rash, rash generalized, rash maculo-papular, rash popular and rash pruritic), pruritis, skin hyperpigmentation, eczema, psoriasis, dry skin, lower respiratory tract infection, thrombocytopenia, edema (general and localized), constipation, hypertriglyceridemia, hypercholesterolemia, oropharyngeal pain, renal impairment, headache, weight increased, hypotension, abdominal pain/abdominal distension, decreased appetite, dehydration, edema(peripheral), upper respiratory tract infection, diarrhea, pain in extremities, arthralgia, fatigue, anaphylactic reaction, back pain, chest pain or discomfort, nausea and vomiting, flushing, erythema, palpitations"
86,SYLVANT,warnings and precautions,"infections, Infusion Related Reactions, anaphylaxis, mild to moderate infusion reaction, Gastrointestinal (GI) perforation"
87,LASTACAFT,adverse reactions,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence"
88,LASTACAFT,warnings and precautions,"eye injury, contamination, contact lens-related irritation"
89,GAZYVA,adverse reactions,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Leukopenia, Urinary tract infection, Back pain, Nasopharyngitis, Constipation, Lymphopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Musculoskeletal Disorders, Liver Enzyme Elevations, Worsening of Pre-existing Cardiac Conditions"
90,GAZYVA,boxed warnings,"Hepatitis B Virus reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML), fatal PML"
91,GAZYVA,warnings and precautions,"infusion reactions, hypotension, tachycardia, dyspnea, respiratory symptoms, bronchospasm, larynx and throat irritation, wheezing, laryngeal edema, nausea, vomiting, diarrhea, hypertension, flushing, headache, pyrexia, chills, anaphylaxis, acute life-threatening respiratory symptoms, other life-threatening infusion reaction, Hepatitis B virus reactivation, fulminant hepatitis, hepatic failure, death, increase in transaminase levels, increase in bilirubin levels, liver failure, Progressive Multifocal Leukoencephalopathy (PML), Tumor Lysis Syndrome (TLS), acute renal failure, hyperkalemia, hypocalcemia, hyperuricemia, hyperphosphatemia, Serious bacterial infections, fungal infections, new or reactivated viral infections, Fatal infections, Grade 3 or 4 neutropenia, late onset neutropenia, prolonged neutropenia, Grade 3 or 4 thrombocytopenia, acute thrombocytopenia, Fatal hemorrhagic events"
92,ONGLYZA,adverse reactions,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, fractures, thrombocytopenia, hypoglycemia, hypersensitivity reactions, urticaria, facial edema, tuberculosis, salmonella sepsis, lymphocyte count decreased, anaphylaxis, angioedema, exfoliative skin conditions, acute pancreatitis, arthralgia"
93,ONGLYZA,warnings and precautions,"Acute Pancreatitis, confirmed hypoglycemia, Hypersensitivity-Related Events, urticaria, facial edema, serious hypersensitivity reactions, anaphylaxis, angioedema, exfoliative skin conditions, Severe and disabling arthralgia"
94,SIVEXTRO,adverse reactions,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, Hemoglobin (<10.1 g/dL [M], <9 g/dL [F]), Platelet count (<112 * 10^3/mm^3), Absolute neutrophil count (<0.8 * 10^3/mm^3), Myelosuppression, Peripheral neuropathy, Optic neuropathy"
95,SIVEXTRO,warnings and precautions,"neutropenia, reduced antibacterial activity in the absence of granulocytes, Clostridium difficile-associated diarrhea, mild diarrhea, fatal colitis, overgrowth of C. difficile, toxins A and B, increased morbidity and mortality, refractory to antibacterial therapy, colectomy, diarrhea following antibiotic use, development of drug-resistant bacteria"
96,PREPOPIK,adverse reactions,"nausea, headache, vomiting, abdominal bloating, distension, pain/cramping, watery diarrhea, electrolyte abnormalities, potassium (low), sodium (low), chloride (low), magnesium (high), calcium (low), creatinine (high), eGFR (low), allergic reactions, rash, urticaria, purpura, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, reversible aphthoid ileal ulcers, ischemic colitis, generalized tonic-clonic seizures"
97,PREPOPIK,warnings and precautions,"fluid and electrolyte abnormalities, arrhythmia, seizures, renal impairment, mucosal ulcerations, GI obstruction, perforation, aspiration, significant vomiting, dehydration, orthostatic hypotension, cardiac arrhythmias, generalized tonic-clonic seizures, hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, renal injury, magnesium accumulation in plasma, serious arrhythmias, prolonged QT, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, cardiomyopathy, colonic mucosal aphthous ulcerations, ischemic colitis, severe active ulcerative colitis, impaired gag reflex, regurgitation, nausea, vomiting"
98,OFEV,adverse reactions,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, hypothyroidism"
99,OFEV,warnings and precautions,"Elevated liver enzymes: ALT, AST, bilirubin elevations, Gastrointestinal disorders: Diarrhea, nausea, vomiting, Embryofetal toxicity, Arterial thromboembolic events, Bleeding events, Gastrointestinal perforation, Liver enzyme increases, Bilirubin elevations, Myocardial infarction"
100,ZONTIVITY,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, GUSTO severe bleeding, GUSTO moderate bleeding, bleeding with hemodynamic compromise requiring intervention, bleeding requiring transfusion of whole blood or packed red blood cells, GUSTO moderate or severe bleeding, Non-CABG-Related Bleeds, Fatal Bleeding, Intracranial Hemorrhage (ICH), Clinically Significant Bleeding, Gastrointestinal Bleeding, Anemia, Depression, Rashes, Eruptions, and Exanthemas, iron deficiency, retinopathy or retinal disorder, diplopia/oculomotor disturbances"
101,ZONTIVITY,boxed warnings,"stroke, transient ischemic attack (TIA), intracranial hemorrhage (ICH), active pathological bleeding, bleeding, fatal bleeding"
102,ZONTIVITY,warnings and precautions,"bleeding, ICH, fatal bleeding, hypotensive"
103,BELVIQ,adverse reactions,"Serotonin Syndrome or NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, headache, dizziness, fatigue, nausea, dry mouth, constipation, back pain, cough, diarrhea, vomiting, upper respiratory tract infection, nasopharyngitis, urinary tract infection, musculoskeletal pain, oropharyngeal pain, sinus congestion, rash, toothache, peripheral edema, seasonal allergy, gastroenteritis, worsening of diabetes mellitus, decreased appetite, muscle spasms, anxiety, insomnia, stress, depression, hypertension, euphoria, suicidal ideation, lymphocyte count decrease, neutrophil count decrease, hemoglobin decrease, eye disorders, blurred vision, dry eye, visual impairment, visual disorders, conjunctival infections, ocular sensation disorders, cataract conditions, valvular regurgitation."
104,BELVIQ,warnings and precautions,"Serotonin Syndrome or Neuroleptic Malignant Syndrome (NMS)-like Reactions, Valvular heart disease, Cognitive Impairment, Psychiatric Disorders, depression, suicidal thoughts, hypoglycemia, Priapism, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, Pulmonary Hypertension, mental status changes, agitation, hallucinations, coma, autonomic instability, tachycardia, labile blood pressure, hyperthermia, neuromuscular aberrations, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, muscle rigidity, rapid fluctuation of vital signs, Regurgitant cardiac valvular disease, mitral regurgitation, aortic regurgitation, congestive heart failure, cardiac murmur, impairments in attention, memory, confusion, somnolence, fatigue, euphoria, hallucination, dissociation, worsening of depression, unusual changes in mood or behavior, bradycardia, heart block, decreases in white blood cell count, leukopenia, lymphopenia, neutropenia, decreased white cell count, decreases in red blood cell count, anemia, decreases in hemoglobin, decreases in hematocrit, galactorrhea, gynecomastia, prolactinoma."
105,STELARA,adverse reactions,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome, Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), RPLS, Serious infections, Non-melanoma skin cancer, Prostate cancer, Melanoma, Colorectal cancer, Breast cancer, Arthralgia, Nausea, Dental infections, Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis."
106,STELARA,warnings and precautions,"Serious infections, Infections, Serious bacterial infections, fungal infections, viral infections, diverticulitis, cellulitis, pneumonia, appendicitis, cholecystitis, sepsis, osteomyelitis, gastroenteritis, urinary tract infections, disseminated infections from mycobacteria, nontuberculous mycobacteria infections, environmental mycobacteria infections, salmonella infections, nontyphi strains infections, Bacillus Calmette-Guerin (BCG) vaccinations infections, tuberculosis, active tuberculosis, latent tuberculosis, malignancy, malignancies, cutaneous squamous cell carcinomas, non-melanoma skin cancer, Hypersensitivity reactions, anaphylaxis, angioedema, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), headache, seizures, confusion, visual disturbances, preeclampsia, eclampsia, acute hypertension, cytotoxic agents, immunosuppressive therapy, fatal outcomes, live vaccines, Non-live vaccinations, Ultraviolet-induced skin cancers."
107,NATROBA,adverse reactions,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin"
108,NATROBA,warnings and precautions,"Benzyl alcohol toxicity, serious adverse reactions, death"
109,ELELYSO,adverse reactions,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, Type III immune-mediated fixed drug eruption, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, mild throat irritation, chest discomfort, anaphylaxis"
110,ELELYSO,warnings and precautions,"hypersensitivity reactions including anaphylaxis, urticaria, hypotension, flushing, wheezing, chest tightness, nausea, vomiting, dizziness, pruritus, angioedema, erythema, rash, cough, throat irritation"
111,STRIVERDI,adverse reactions,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, worsening COPD, COPD exacerbation, pneumonia, atrial fibrillation, constipation, pyrexia, lung cancers"
112,STRIVERDI,boxed warnings,asthma-related death
113,STRIVERDI,warnings and precautions,"clinically significant cardiovascular effects, fatal, Life-threatening paradoxical bronchospasm, increase the risk of asthma-related death, asthma-related deaths, deterioration of disease, acute episodes of bronchospasm, paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, symptoms, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, aggravate pre-existing diabetes mellitus and ketoacidosis, significant hypokalemia, adverse cardiovascular effects, increases in plasma glucose, susceptibility for cardiac arrhythmias, Immediate hypersensitivity reactions, angioedema"
114,BELSOMRA,adverse reactions,"CNS depressant effects, daytime impairment, Abnormal thinking, behavioral changes, Worsening of Depression, Suicidal ideation, Sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, somnolence, Diarrhea, Dry mouth, Upper respiratory tract infection, Headache, Dizziness, Abnormal dreams, Cough, increase in serum cholesterol"
115,BELSOMRA,warnings and precautions,"Daytime somnolence, impaired alertness, motor coordination impairment, impaired driving, insomnia persistence, ""sleep-driving"", complex behaviors while not fully awake, worsening of depression, suicidal thinking, compromised respiratory function, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, somnolence, CNS depressant effects, driving skills impairment, risk of falling asleep while driving, cognitive and behavioral abnormalities, amnesia, anxiety, hallucinations, neuro-psychiatric symptoms, dose-dependent increase in suicidal ideation, worsening of depression, suicidal thoughts and actions, completed suicides, intentional overdose, inability to move or speak, vivid and disturbing perceptions, leg weakness."
116,NPLATE,adverse reactions,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsening thrombocytopenia, erythromelalgia, hypersensitivity, angioedema"
117,NPLATE,warnings and precautions,"progression to acute myelogenous leukemia, increased blast cell counts, Thrombotic/thromboembolic complications, Portal vein thrombosis, worsened thrombocytopenia, formation of neutralizing antibodies, marrow fibrosis with collagen, thrombocytopenia of greater severity, Hyporesponsiveness or failure to maintain a platelet response, neutralizing antibodies to Nplate and thrombopoietin"
118,ORBACTIV,adverse reactions,"Hypersensitivity Reactions, Infusion related reactions, Clostridium difficile-associated diarrhea, Osteomyelitis, headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea, cellulitis, dizziness, Infusion site phlebitis, Infusion site reaction, Alanine aminotransferase increased, Aspartate aminotransferase increased, Tachycardia, anemia, eosinophilia, infusion site erythema, extravasation, induration, pruritis, rash, edema peripheral, hypersensitivity, osteomyelitis, total bilirubin increased, hyperuricemia, hypoglycemia, tenosynovitis, myalgia, bronchospasm, wheezing, urticaria, angioedema, erythema multiforme, pruritis, leucocytoclastic vasculitis, rash"
119,ORBACTIV,warnings and precautions,"risk of bleeding, artificially prolong aPTT, prolong PT and INR, hypersensitivity reactions, acute hypersensitivity, infusion-related reactions, pruritus, urticaria, flushing, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, morbidity, mortality, osteomyelitis"
120,MEKINIST,adverse reactions,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, rash, diarrhea, lymphedema, pyrexia, chills, fatigue, nausea, vomiting, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, decreased left ventricular ejection fraction (LVEF), pneumonitis, renal failure, stomatitis, hypertension, RPED, RVO, Bradycardia, Xerostomia, Folliculitis, rash pustular, cellulitis, Rhabdomyolysis, Dizziness, dysgeusia, Vision blurred, dry eye, Increased aspartate aminotransferase (AST), Increased alanine aminotransferase (ALT), Hypoalbuminemia, Anemia, Increased alkaline phosphatase, Edema peripheral, Dermatitis acneiform, Actinic keratosis, Erythema, Pruritus, Vomiting, Constipation, Dry mouth, Oropharyngeal pain, Arthralgia, Myalgia, Back pain, Muscle spasms, Pain in extremity, Decreased appetite, Dehydration, Insomnia, Hemorrhage, Urinary tract infection, Renal failure, Vision blurred, transient blindness, Stomatitis, pancreatitis, Asthenia, Cellulitis, paronychia, Skin papilloma, Palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, Hypertension, Leukopenia, Lymphopenia, Neutropenia, Thrombocytopenia, Increased AST, Increased alkaline phosphatase, Increased ALT, Hyperbilirubinemia, Hyperglycemia, Increased GGT, Hyponatremia, Hypophosphatemia, Hypokalemia, Increased creatinine, Hypomagnesemia, Hyperkalemia, Hypercalcemia, Hypocalcemia, QT Prolongation"
121,MEKINIST,warnings and precautions,"Tumor promotion in patients with BRAF wild-type melanoma, Hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, New primary malignancies, cutaneous and non-cutaneous, Hemorrhage, Major hemorrhagic events, Venous Thromboembolism, Deep vein thrombosis, Pulmonary embolism, Cardiomyopathy, Ocular Toxicities, Retinal Vein Occlusion (RVO), Interstitial Lung Disease (ILD), Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Embryofetal Toxicity, basal cell carcinoma, Cutaneous squamous cell carcinomas (SCC), keratoacanthoma, New primary melanoma, Intracranial hemorrhage, gastric hemorrhage, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, fever, hypotension, rigors or chills, dehydration, renal failure, dermatitis acneiform rash, palmar-plantar erythrodysesthesia syndrome, erythema, secondary infections of the skin, Grade 3 hyperglycemia, embryotoxic, abortifacient."
122,CYRAMZA,adverse reactions,"Hemorrhage, Arterial Thromboembolic Events, Hypertension, Infusion-Related Reactions, Gastrointestinal Perforation, Impaired Wound Healing, Reversible Posterior Leukoencephalopathy Syndrome, Proteinuria Including Nephrotic Syndrome, Thyroid Dysfunction, hypertension, diarrhea, fatigue, neutropenia, epistaxis, fatigue/asthenia, stomatitis/mucosal inflammation, decreased appetite, anemia, intestinal obstruction, red blood cell transfusions, hyponatremia, headache, neutropenia, rash, arterial thromboembolic events, gastrointestinal perforation, infusion-related reactions, febrile neutropenia, granulocyte colony-stimulating factors, thrombocytopenia, gastrointestinal hemorrhage events, stomatitis, fatigue/asthenia, peripheral edema, hypoalbuminemia, proteinuria, hypertension, sepsis, gastrointestinal perforations, febrile neutropenia, pneumonia, neutropenia, granulocyte colony-stimulating factors, pulmonary hemorrhage, infusion-related reaction, lacrimation increased, peripheral edema, epistaxis, hyponatremia, proteinuria, diarrhea, intestinal obstruction, febrile neutropenia, neutropenia, thrombocytopenia, decreased appetite, gastrointestinal hemorrhage events, stomatitis, peripheral edema, hypoalbuminemia, proteinuria, epistaxis, palmar-plantar erythrodysesthesia syndrome, hypertension, gastrointestinal perforation, increased TSH levels, treatment-emergent anti-ramucirumab antibodies, neutralizing antibodies."
123,CYRAMZA,boxed warnings,"hemorrhage, gastrointestinal hemorrhage, severe hemorrhagic events, fatal hemorrhagic events, severe bleeding, gastrointestinal perforation, impaired wound healing, wound healing complications"
124,CYRAMZA,warnings and precautions,"arterial thromboembolic events, fatal arterial thromboembolic events, myocardial infarction, cardiac arrest, cerebrovascular accident, cerebral ischemia, hypertension, severe hypertension, medically significant hypertension, hypertensive crisis, hypertensive encephalopathy, infusion-related reactions, rigors/tremors, back pain/spasms, chest pain, tightness, chills, flushing, dyspnea, wheezing, hypoxia, paresthesia, bronchospasm, supraventricular tachycardia, hypotension, hemorrhage, gastrointestinal hemorrhage, severe bleeding, severe hemorrhagic events, gastrointestinal perforation, impaired wound healing, new onset encephalopathy, worsening encephalopathy, ascites, hepatorenal syndrome, reversible posterior leukoencephalopathy syndrome, proteinuria, nephrotic syndrome, thyroid dysfunction, hypothyroidism, embryofetal risk, fetal harm"
125,RAXIBACUMAB,adverse reactions,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
126,RAXIBACUMAB,warnings and precautions,"infusion reactions, rash, urticaria, pruritus"
127,ARCALYST,adverse reactions,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, injection-site reaction (ISR), upper respiratory infection, nausea, diarrhea, abdominal pain upper, cough, hypoesthesia, stomach discomfort, urinary tract infection, erythema, swelling, pruritis, mass, bruising, inflammation, pain, edema, dermatitis, discomfort, urticaria, vesicles, warmth, hemorrhage, transient neutropenia"
128,ARCALYST,warnings and precautions,"serious infections, life-threatening infections, hypersensitivity reactions, severe bronchitis, bacterial meningitis, increased risk of serious infections, increased risk of reactivation of latent tuberculosis, increase in the risk of malignancies, changes in lipid profiles"
129,RAPIVAB,adverse reactions,"Serious skin and hypersensitivity reactions, Neuropsychiatric Events, diarrhea, Alanine Aminotransferase (> 2.5 * ULN), Serum Glucose (> 160 mg/dL), Creatine Phosphokinase (>= 6.0 * ULN), Neutrophils (< 1.000 *10^9/L), constipation, insomnia, AST increased, hypertension, Stevens-Johnson Syndrome, exfoliative dermatitis, rash, abnormal behavior, hallucination"
130,RAPIVAB,warnings and precautions,"Serious skin/hypersensitivity reactions, Stevens-Johnson syndrome, erythema multiforme, hallucinations, delirium, abnormal behavior, neurologic and behavioral symptoms, encephalitis, encephalopathy, delirium and abnormal behavior leading to injury, secondary bacterial infections"
131,FOLOTYN,adverse reactions,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, thrombocytopenia, nausea, fatigue, pyrexia, sepsis, febrile neutropenia, dehydration, dyspnea, anemia, constipation, edema, cough, epistaxis, vomiting, neutropenia, diarrhea, anorexia, hypokalemia, rash, pruritus, pharyngolaryngeal pain, liver function test abnormal, abdominal pain, pain in extremity, back pain, leukopenia, night sweats, asthenia, tachycardia, upper respiratory tract infection, cardiopulmonary arrest, pancytopenia, Toxic epidermal necrolysis"
132,FOLOTYN,warnings and precautions,"Thrombocytopenia, neutropenia, anemia, Grade 2 mucositis, Dermatologic reactions, fatal reactions, Tumor lysis syndrome, Hepatic toxicity, liver function test abnormalities, Increased toxicity with renal impairment, Embryo-Fetal toxicity, bone marrow suppression, skin exfoliation, ulceration, toxic epidermal necrolysis (TEN), mucositis, hepatic toxicity, Serious adverse drug reactions, toxic epidermal necrolysis, fetal harm, embryotoxic, fetotoxic"
133,KRYSTEXXA,adverse reactions,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, urticaria, dyspnea, chest discomfort, erythema, pruritus, congestive heart failure exacerbation"
134,KRYSTEXXA,boxed warnings,"anaphylaxis, infusion reactions, delayed-type hypersensitivity reactions"
135,KRYSTEXXA,warnings and precautions,"Anaphylaxis, wheezing, peri-oral or lingual edema, hemodynamic instability, rash, urticaria, Infusion Reactions, Gout Flares, Congestive Heart Failure exacerbation"
136,NUCYNTA,adverse reactions,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, and dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, fatigue, feeling hot, nasopharyngitis, upper respiratory tract infection, urinary tract infection, decreased appetite, tremor, lethargy, insomnia, confusional state, abnormal dreams, anxiety, pruritus, hyperhidrosis, pruritus generalized, rash, hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, anaphylaxis, angioedema, anaphylactic shock"
137,NUCYNTA,warnings and precautions,"misuse, abuse, addiction, overdose, death, respiratory depression, respiratory arrest, ""sighing"" pattern of breathing, Carbon dioxide (CO2) retention, sedating effects of opioids, fatal respiratory depression, hypoxia, hypercarbia, decreased respiratory reserve, increased airway resistance, apnea, hypotension, profound sedation, coma, vasodilation, reduced cardiac output, increased intracranial pressure, brain tumors, impaired consciousness, coma, convulsions, seizure disorders, worsened seizure control, serotonin syndrome, mental-status changes, autonomic instability, neuromuscular aberrations, gastrointestinal symptoms, GI obstruction, paralytic ileus, spasm of the sphincter of Oddi, acute pancreatitis, withdrawal symptoms, anxiety, sweating, insomnia, rigors, pain, nausea, tremors, diarrhea, upper respiratory symptoms, piloerection, hallucinations, impaired mental abilities, impaired physical abilities, hepatic impairment, elevated serum concentrations of tapentadol, renal impairment, accumulation of metabolite."
138,ACTEMRA,adverse reactions,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforation, generalized purulent peritonitis, lower GI perforation, fistula, abscess, infusion reactions, hypertension, headache, skin reactions, rash, pruritus, urticaria, anaphylaxis, neutropenia, thrombocytopenia, elevated liver enzymes, liver enzyme abnormalities, AST increased, ALT increased, lipids, elevated lipids, total cholesterol increased, LDL increased, HDL increased, LDL/HDL ratio increased, ApoB/ApoA1 ratio, immunogenicity, anti-tocilizumab antibodies, neutralizing antibodies, malignancies, upper respiratory tract infection, dizziness, bronchitis, rash, mouth ulceration, abdominal pain upper, gastritis, transaminase increased, oral herpes simplex, stomatitis, gastric ulcer, weight increased, total bilirubin increased, leukopenia, edema peripheral, dyspnea, cough, conjunctivitis, nephrolithiasis, hypothyroidism, injection site reactions, erythema, pain, hematoma, macrophage activation syndrome (MAS), infusion-related reactions, angioedema, serious adverse events, urticaria, epigastric discomfort, arthralgia, diarrhea, Stevens-Johnson Syndrome, fatal anaphylaxis."
139,ACTEMRA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, pulmonary disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, candidiasis, aspergillosis, pneumocystis, disseminated disease, localized disease, bacterial infections, viral infections, opportunistic pathogens"
140,ACTEMRA,warnings and precautions,"serious infections, active infection, localized infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, tuberculosis, cryptococcus, aspergillosis, candidiasis, pneumocystosis, histoplasmosis, coccidioidomycosis, listeriosis, disseminated disease, Gastrointestinal (GI) perforation, neutropenia, thrombocytopenia, elevated liver enzymes, lipid abnormalities, malignancies, hypersensitivity reactions, anaphylaxis, death, Viral reactivation, hepatitis B reactivation, herpes zoster exacerbation, Demyelinating disorders, multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, Active hepatic disease, hepatic impairment, Vaccinations, live vaccines"
141,VIIBRYD,adverse reactions,"Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, nausea (1.4%), Diarrhea, Nausea, Dry mouth, Vomiting, Abdominal pain, Dyspepsia, Flatulence, Gastroenteritis, Abdominal distension, Headache, Dizziness, Somnolence, Paresthesia, Insomnia, Abnormal dreams, Restlessness, Fatigue, Palpitations, Increased appetite, Arthralgia, Increased weight, Abnormal Orgasm, Erectile dysfunction, Libido decreased, Ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt, suicidal ideation, rash, generalized rash, urticaria, drug eruption"
142,VIIBRYD,boxed warnings,"SUICIDAL THOUGHTS AND BEHAVIORS, clinical worsening"
143,VIIBRYD,warnings and precautions,"Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania/Hypomania, Seizures, Angle Closure Glaucoma, Suicidal Thoughts and Behavior in Children, Adolescents and Young Adults, mental status changes, autonomic instability, neuromuscular symptoms, gastrointestinal symptoms, ecchymosis, hematoma, epistaxis, petechiae, life-threatening hemorrhages, Discontinuation Syndrome, Hyponatremia, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death"
144,LUZU,adverse reactions,"application site reactions, contact dermatitis, cellulitis"
145,LUMASON,adverse reactions,"Severe cardiopulmonary reactions, Hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope symptoms, anaphylactic shock, Dysgeusia, Injection site pain, Chest discomfort, Feeling Hot, Chest pain, Injection Site Warmth, fatalities, arrhythmias, hypertensive episodes"
146,LUMASON,boxed warnings,"serious cardiopulmonary reactions, fatalities"
147,LUMASON,warnings and precautions,"Cardiopulmonary reactions, fatalities, Anaphylactoid reactions, fatal cardiac or respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, chest pain, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, anaphylactic shock, systemic embolization, tissue ischemia, ventricular arrhythmias"
148,LYNPARZA,adverse reactions,"Myelodysplastic syndrome, Acute Myeloid Leukemia, Pneumonitis, anemia, nausea, fatigue, asthenia, vomiting, diarrhea, dysgeusia, dyspepsia, headache, decreased appetite, nasopharyngitis, pharyngitis, URI, cough, arthralgia, musculoskeletal pain, myalgia, back pain, dermatitis, rash, abdominal pain, discomfort, increase in creatinine, mean corpuscular volume elevation, decrease in hemoglobin, decrease in lymphocytes, decrease in absolute neutrophil count, decrease in platelets, COPD, cerebrovascular accident, intestinal perforation, pulmonary embolism, sepsis, suture rupture, constipation, peripheral edema, dizziness, urinary tract infection, dyspnea, leukopenia, stomatitis, peripheral neuropathy, pyrexia, hypomagnesemia, hyperglycemia, anxiety, depression, insomnia, dysuria, urinary incontinence, vulvovaginal disorder, dry skin, eczema, pruritis, hypertension, venous thrombosis, hot flush."
149,LYNPARZA,warnings and precautions,"Myelodysplastic syndrome/Acute Myeloid Leukemia, some cases were fatal, hematological toxicity, Pneumonitis, some cases were fatal, Embryo-Fetal toxicity, fetal harm, teratogenic, embryo-fetal toxicity, dyspnea, fever, cough, wheezing, radiological abnormality"
150,EGRIFTA,adverse reactions,"hypersensitivity, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, injection site irritation, swelling, hemorrhage, myalgia, musculoskeletal pain, musculoskeletal stiffness, joint stiffness, muscle spasms, joint swelling, edema peripheral, injection site pain, chest pain, injection site rash, paresthesia, hypoesthesia, nausea, vomiting, dyspepsia, abdominal pain upper, palpitations, depression, night sweats, hypertension, muscle strain, blood creatine phosphokinase increased, diabetes, neuropathy peripheral, insomnia, hot flush"
151,EGRIFTA,warnings and precautions,"edema, arthralgia, carpal tunnel syndrome, glucose intolerance, rash, urticaria, injection site reactions, pruritus, erythema, flushing, injection site erythema, injection site pruritus, injection site pain, injection site irritation, injection site bruising, increased mortality, acute critical illness"
152,ELLA,adverse reactions,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, acne"
153,ELLA,warnings and precautions,"ectopic pregnancy, alter the next expected menses, delay of menses beyond 1 week, intermenstrual bleeding, menses occurring more than 7 days earlier, delay of more than 7 days, decreased plasma concentration of ella, reduce the contraceptive action of regular hormonal contraceptive methods"
154,ZALTRAP,adverse reactions,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), leukopenia, AST increased, stomatitis, fatigue, thrombocytopenia, ALT increased, weight decreased, decreased appetite, epistaxis, abdominal pain, dysphonia, serum creatinine increased, headache, asthenia, Urinary Tract Infection, Dyspnea, Oropharyngeal Pain, Rhinorrhea, Abdominal Pain Upper, Hemorrhoids, Rectal Hemorrhage, Proctalgia, Palmar-Plantar Erythrodysesthesia Syndrome, Skin Hyperpigmentation, severe hypersensitivity reactions, venous thromboembolic events, deep venous thrombosis, pulmonary embolism"
155,ZALTRAP,boxed warnings,"Severe hemorrhage, fatal hemorrhage, gastrointestinal (GI) hemorrhage, GI bleeding, severe bleeding, Gastrointestinal (GI) perforation, fatal GI perforation, Severe compromised wound healing."
156,ZALTRAP,warnings and precautions,"fistula formation, hypertension, hypertensive crisis, arterial thromboembolic events, transient ischemic attacks, cerebrovascular accident, angina pectoris, proteinuria, nephrotic syndrome, thrombotic microangiopathy, neutropenia, neutropenic complications, diarrhea, dehydration, reversible posterior leukoencephalopathy syndrome, hemorrhage, severe hemorrhagic events, gastrointestinal hemorrhage, hematuria, post-procedural hemorrhage, intracranial hemorrhage, pulmonary hemorrhage/hemoptysis, gastrointestinal perforation, compromised wound healing, Grade 3 compromised wound healing, Grade 3 GI fistula formation, Grade 3-4 hypertension, Grade 3-4 proteinuria, Grade 3-4 neutropenia, Grade 3-4 febrile neutropenia, Grade 3-4 neutropenic infection/sepsis, Grade 3-4 diarrhea, Grade 3-4 dehydration"
157,MYRBETRIQ,adverse reactions,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, sinusitis, influenza, arthralgia, cystitis, dry eyes, vision blurred, cerebrovascular accident, osteoarthritis, neoplasm, breast cancer, lung neoplasm malignant, Stevens-Johnson syndrome, angioedema, urinary retention"
158,MYRBETRIQ,warnings and precautions,"Increases in Blood Pressure, Urinary Retention, Angioedema, Worsening of pre-existing hypertension, dose-related increases in supine blood pressure, increased urinary retention, Angioedema of the face, lips, tongue, and/or larynx, Angioedema associated with upper airway swelling, systemic exposure to CYP2D6 substrates increased"
159,EDURANT,adverse reactions,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, depressive disorders, headache, insomnia, rash, psychiatric disorders, abdominal pain, nausea, vomiting, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, Increased Creatinine, Increased AST, Increased ALT, Increased Total Bilirubin, Increased Total Cholesterol (fasted), Increased LDL Cholesterol (fasted), Increased Triglycerides (fasted), adrenal insufficiency, nephrotic syndrome, Severe skin and hypersensitivity reactions including DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)"
160,EDURANT,warnings and precautions,"Severe skin and hypersensitivity reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), rash with systemic symptoms, elevations in hepatic serum biochemistries, Severe depressive disorders, depressed mood, depression, dysphoria, major depression, mood altered, negative thoughts, suicide attempt, suicidal ideation, Hepatic adverse events, hepatitis B or C co-infection, elevated baseline transaminases, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, tuberculosis, Autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
161,HARVONI,adverse reactions,"fatigue, headache, nausea, diarrhea, insomnia, Bilirubin elevations, Lipase Elevations, Creatine Kinase, Serious symptomatic bradycardia"
162,HARVONI,warnings and precautions,"serious symptomatic bradycardia, fatal cardiac arrest, cases requiring pacemaker intervention, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
163,OSPHENA,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), Vascular Disorders, Reproductive System and Breast Disorders, Musculoskeletal and Connective Tissue Disorders, Skin and Subcutaneous Tissue Disorders, Immune System Disorders, allergic conditions, hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria"
164,OSPHENA,boxed warnings,"endometrial cancer, increased risk of endometrial cancer, endometrial hyperplasia, stroke, deep vein thrombosis (DVT), thromboembolic stroke, hemorrhagic stroke"
165,OSPHENA,warnings and precautions,"Venous Thromboembolism, Risk of DVT, pulmonary embolism, cardiovascular disorders, arterial vascular disease, hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, obesity, venous thromboembolism, personal history of VTE, family history of VTE, systemic lupus erythematosus, Stroke, increased risk of stroke, thromboembolic stroke, hemorrhagic stroke, Coronary Heart Disease, nonfatal MI, silent MI, CHD death, single MI, increased risk of VTE, increased risk of DVT, Endometrial Cancer, simple hyperplasia without atypia, Endometrial thickening, proliferative endometrium, Uterine polyps, increased risk of endometrial cancer, endometrial hyperplasia, increased risk of breast cancer, Breast Cancer, Severe Hepatic Impairment"
166,ERIVEDGE,adverse reactions,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia"
167,ERIVEDGE,boxed warnings,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, severe midline defects, missing digits, irreversible malformations"
168,ERIVEDGE,warnings and precautions,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic"
169,LATUDA,adverse reactions,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions Including Stroke, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes (Hyperglycemia and Diabetes Mellitus, Dyslipidemia, Weight Gain), Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Neurological Adverse Reactions in Patients with Parkinson's Disease or Dementia with Lewy Bodies, somnolence, akathisia, extrapyramidal symptoms, nausea, vomiting, dyspepsia, salivary hypersecretion, back pain, dizziness, insomnia, agitation, anxiety, restlessness, diarrhea, nasopharyngitis, influenza, urinary tract infection, fatigue, weight increased, increased appetite, dystonia, parkinsonism, anemia, tachycardia, AV block 1st degree, angina pectoris, bradycardia, vertigo, blurred vision, abdominal pain, gastritis, sudden death, CPK increased, decreased appetite, rhabdomyolysis, cerebrovascular accident, dysarthria, abnormal dreams, panic attack, sleep disorder, dysuria, renal failure, amenorrhea, dysmenorrhea, breast enlargement, breast pain, galactorrhea, erectile dysfunction, rash, pruritus, angioedema, hypertension, serum creatinine increased"
170,LATUDA,boxed warnings,"INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS, SUICIDAL THOUGHTS AND BEHAVIORS, increased risk of death, Increased risk of suicidal thinking and behavior in children, adolescents, and young adults, Monitor for worsening and emergence of suicidal thoughts and behaviors"
171,LATUDA,warnings and precautions,"Cerebrovascular adverse events (e.g., stroke, transient ischemic attack), Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Dizziness, Tachycardia, Bradycardia, Increased Mortality, Suicidal Thoughts and Behaviors, Suicidality, Anxiety, Agitation, Panic Attacks, Insomnia, Irritability, Hostility, Aggressiveness, Impulsivity, Akathisia (psychomotor restlessness), Hypomania, Mania, Seizures, Cognitive Impairment, Motor Impairment, Somnolence, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Confusion, Obtundation, Postural Instability, Falls, Extrapyramidal Symptoms, Neuroleptic Malignant Syndrome-like Symptoms"
172,LEXISCAN,adverse reactions,"Myocardial Ischemia, Sinoatrial and Atrioventricular Nodal Block, Atrial Fibrillation/Atrial Flutter, Hypersensitivity Including Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident (Stroke), dyspnea, headache, flushing, chest discomfort, dizziness, angina pectoris, chest pain, nausea, Abdominal Discomfort, Dysgeusia, Feeling Hot, rhythm abnormalities, PACs, PVCs, First-degree AV block, Second-degree AV block, AV conduction abnormalities, Ventricular conduction abnormalities, Wheezing, FEV1 reduction >15%, Myocardial infarction, cardiac arrest, ventricular arrhythmias, supraventricular tachyarrhythmias, heart block, asystole, marked hypertension, symptomatic hypotension, transient ischemic attack, QTc prolongation, Tremor, transient ischemic attack, cerebrovascular accident, intracranial hemorrhage, Abdominal pain, nausea, vomiting, myalgias, Diarrhea, fecal incontinence, Anaphylaxis, angioedema, cardiac or respiratory arrest, respiratory distress, decreased oxygen saturation, throat tightness, urticaria, rashes, Musculoskeletal pain, Respiratory arrest, dyspnea, wheezing"
173,LEXISCAN,warnings and precautions,"Myocardial Ischemia, Fatal cardiac events, Sinoatrial (SA) and Atrioventricular (AV) Nodal Block, first-degree AV block, second-degree AV block, third-degree AV block, sinus bradycardia, Atrial Fibrillation/Atrial Flutter, Hypersensitivity, Anaphylaxis, angioedema, cardiac arrest, respiratory arrest, respiratory distress, decreased oxygen saturation, hypotension, throat tightness, urticaria, rashes, Hypertension, Bronchoconstriction, dyspnea, Seizure, convulsive seizures, Cerebrovascular Accident (Stroke), Hemorrhagic cerebrovascular accidents, ischemic cerebrovascular accidents, ventricular arrhythmias, transient ischemic attacks, syncope, PR prolongation, dropped beat, asystole, decreased systolic blood pressure, decreased diastolic blood pressure, left main coronary artery stenosis, stenotic valvular heart disease, pericarditis, pericardial effusions, stenotic carotid artery disease with cerebrovascular insufficiency, emergent anticonvulsive management, clinically significant increases in blood pressure, bronchoconstriction, respiratory compromise, Hemodynamic effects"
174,BRILINTA,adverse reactions,"Bleeding 12%, Dyspnea 14%, PLATO Major + Minor 713 (7.7%), Major 362 (3.9%), Fatal/Life-threatening 171 (1.9%), Fatal 15 (0.2%), Intracranial hemorrhage (Fatal/Life-threatening) 26 (0.3%), PLATO Total Major 626 (81.3%), Fatal/Life-threatening 337 (43.8%), Fatal 6 (0.8%), Dyspnea 13.8%, Dizziness 4.5%, Nausea 4.3%, TIMI Major 115 (1.7%), Fatal 11 (0.2%), Intracranial hemorrhage 28 (0.4%), TIMI Major or Minor 168 (2.4%), Dyspnea 14.2%, Dizziness 4.5%, Diarrhea 3.3%, ventricular pauses 6.0%, syncope 1.7%, pre-syncope, loss of consciousness, syncope 1.2%, Serum Uric Acid increase 0.6 mg/dL, gout 0.6%, Serum Creatinine >50% increase 7.4%, renal-related serious adverse events."
175,BRILINTA,boxed warnings,"significant bleeding, fatal bleeding, active pathological bleeding, history of intracranial hemorrhage, subsequent cardiovascular events"
176,BRILINTA,warnings and precautions,"Dyspnea, risk of bleeding, bleeding, study drug discontinuation, myocardial infarction, stroke, death, severe hepatic impairment"
177,KERYDIN,adverse reactions,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis, skin irritation"
178,ZELBORAF,adverse reactions,"New Primary Malignancies, Hypersensitivity Reactions, Dermatologic Reactions, QT Prolongation, Hepatotoxicity, Photosensitivity, Ophthalmologic Reactions, Radiation Sensitization and Radiation Recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, Rash, Photosensitivity reaction, Alopecia, Pruritus, Hyperkeratosis, Rash maculo-papular, Actinic keratosis, Dry skin, Rash papular, Erythema, Arthralgia, Myalgia, Pain in extremity, Musculoskeletal pain, Back pain, Fatigue, Edema peripheral, Pyrexia, Asthenia, Nausea, Diarrhea, Vomiting, Constipation, Headache, Dysgeusia, Skin papilloma, Cutaneous SCC, Seborrheic keratosis, Gamma-glutamyltransferase increased, Decreased appetite, Cough, Sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, GGT, AST, ALT, Alkaline phosphatase, Bilirubin, Progression of pre-existing chronic myelomonocytic leukemia with NRAS mutation, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Neutropenia, Radiation sensitization and recall, Pancreatitis"
179,ZELBORAF,warnings and precautions,"New Primary Cutaneous Malignancies, New Non-Cutaneous Squamous Cell Carcinoma, Other Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Serious Hypersensitivity Reactions, anaphylaxis, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome), Severe Dermatologic Reactions, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, QT Prolongation, Hepatotoxicity, Photosensitivity, Serious Ophthalmologic Reactions, uveitis, Embryo-Fetal Toxicity, Radiation Sensitization, Radiation Recall, Cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, Non-Cutaneous Squamous Cell Carcinoma, Increased cell proliferation, generalized rash, erythema, hypotension, Concentration-dependent QT prolongation, ventricular arrhythmias, Torsade de Pointes, Liver injury, functional hepatic impairment, coagulopathy, organ dysfunction, Mild to severe photosensitivity, blurry vision, photophobia, iritis, Radiation sensitization and recall"
180,FYCOMPA,adverse reactions,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness and Gait Disturbance, Somnolence and Fatigue, Falls, dizziness, somnolence, fatigue, irritability, falls, nausea, weight gain, vertigo, ataxia, headache, vomiting, contusion, abdominal pain, anxiety, aggression, anger, blurred vision, dysarthria, balance disorder, back pain, cough, upper respiratory tract infection, hypersomnia, euphoric mood, confusional state, hyponatremia, limb injury, mood altered, arthralgia, asthenia, memory impairment, musculoskeletal pain, oropharyngeal pain, paraesthesia, peripheral edema, skin laceration, urinary tract infection, ligament sprain, rash, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)."
181,FYCOMPA,boxed warnings,"aggression, hostility, irritability, anger, homicidal ideation and threats"
182,FYCOMPA,warnings and precautions,"Suicidal Behavior and Ideation, Neurologic Effects, dizziness, gait disturbance, somnolence, fatigue, Falls, increase in seizure frequency, hostility- and aggression-related adverse reactions, irritability, aggression, anger, anxiety, belligerence, affect lability, agitation, physical assault, serious and life-threatening, Homicidal ideation and/or threat, paranoia, euphoric mood, mental status changes, disorientation/confusional state, disorientation, delusion, paranoia, depression, suicidal thoughts or behavior, unusual changes in mood or behavior, Dizziness and Gait Disturbance, vertigo, ataxia, balance disorder, abnormal coordination, Somnolence and Fatigue, asthenia, lethargy, increased risk of falls, serious injuries, head injuries, bone fracture, increased seizure frequency, seizures following discontinuation"
183,ISTODAX,adverse reactions,"Myelosuppression, Infection, Electrocardiographic Changes, Tumor Lysis Syndrome, neutropenia, lymphopenia, thrombocytopenia, infections, nausea, fatigue, vomiting, anorexia, anemia, ECG T-wave changes, Asthenia/Fatigue, Hypomagnesemia, Diarrhea, Pyrexia, Dysgeusia, Constipation, Hypotension, Pruritus, Hypokalemia, Dermatitis/Exfoliative dermatitis, Hypocalcemia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hypoalbuminemia, Electrocardiogram ST-T wave changes, Hyperglycemia, Hyponatremia, Hypermagnesemia, Hypophosphatemia, Hyperuricemia, sepsis, supraventricular arrhythmia, central line infection, edema, ventricular arrhythmia, dehydration, catheter related infection, dyspnea, cardiopulmonary failure, acute renal failure, myocardial ischemia, acute respiratory distress syndrome, QT prolongation, Gastrointestinal disorders, Abdominal pain, Stomatitis, General disorders and administration site conditions, Chills, Edema peripheral, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Headache, Respiratory, thoracic and mediastinal disorders, Cough, Investigations, Weight decreased, Cardiac disorders, Tachycardia, pneumonia, cellulitis, deep vein thrombosis, febrile neutropenia, chest pain, pulmonary embolism, multi-organ failure/sepsis, septic shock, candida sepsis, sepsis/cardiogenic shock, aspartate aminotransferase elevation, Epstein Barr virus reactivation, hypersensitivity, pneumonitis, packed red blood cell transfusion, platelet transfusion, hepatitis B virus infection."
184,ISTODAX,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, Fatal and serious infections, pneumonia, sepsis, viral reactivation, Epstein Barr viral infection, hepatitis B virus infection, liver failure, treatment-emergent morphological changes in ECGs, T-wave changes, ST-segment changes, Tumor lysis syndrome (TLS), embryocidal effects, adverse effects on the developing fetus"
185,ZIOPTAN,adverse reactions,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus including allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis/uveitis, deepening of the eyelid sulcus"
186,ZIOPTAN,warnings and precautions,"Pigmentation of the iris, Pigmentation of the periorbital tissue (eyelid), Pigmentation of eyelashes, Iris pigmentation likely to be permanent, Increased length of eyelashes, Increased thickness of eyelashes, Increased number of lashes, Eyelash changes usually reversible, Increased pigmentation of the iris, Increased pigmentation of the periorbital tissue, Increased melanin content in the melanocytes, Pigmentation change due to increased melanin, Pigmentation of the iris permanent after discontinuation, Pigmentation of the periorbital tissue reversible in some patients, Eyelash changes reversible in some patients, Iris color change, Brown pigmentation around the pupil spreads concentrically, Entire iris or parts of the iris become more brownish, Increased length of eyelashes due to ZIOPTAN, Increased color of eyelashes, Increased thickness of eyelashes, Changed shape of eyelashes, Increased number of lashes, Intraocular inflammation may be exacerbated, Macular edema, Cystoid macular edema."
187,SIGNIFOR,adverse reactions,"Hypocortisolism, Hyperglycemia and Diabetes, Bradycardia and QT prolongation, Liver Test Elevations, Cholelithiasis, Pituitary Hormone Deficiency, diarrhea, nausea, hyperglycemia, cholelithiasis, headache, abdominal pain, fatigue, diabetes mellitus, serious adverse events, study discontinuation, Injection site reactions, Nasopharyngitis, Alopecia, Asthenia, Glycosylated hemoglobin increased, Alanine aminotransferase increased, Gamma-glutamyl transferase increased, Edema peripheral, Abdominal pain upper, Decreased appetite, Hypercholesterolemia, Hypertension, Dizziness, Hypoglycemia, Type 2 diabetes mellitus, Anxiety, Influenza, Insomnia, Myalgia, Arthralgia, Pruritus, Lipase increased, Constipation, Hypotension, Vomiting, Back pain, Dry skin, Electrocardiogram QT prolonged, Hypokalemia, Pain in extremity, Sinus bradycardia, Vertigo, Abdominal distension, Adrenal insufficiency, Aspartate aminotransferase increased, Blood glucose increased, anemia, blood amylase increased, prothrombin time prolonged, vomiting, transient mean elevations in aminotransferase values, jaundice, Hypocortisolism, local pain, erythema, hematoma, hemorrhage, pruritus, Hypothyroidism, elevations in lipase and amylase, Pancreatitis, decreases in hemoglobin, elevations in PT and PTT."
188,SIGNIFOR,warnings and precautions,"hypocortisolism, biochemical and/or clinical hypocortisolism, Hyperglycemia, Diabetes, Bradycardia, QT Prolongation, Liver Test Elevations, Cholelithiasis, weakness, fatigue, anorexia, nausea, vomiting, hypotension, hyponatremia, hypoglycemia, pre-diabetes, severe hyperglycemia, ketoacidosis, high-grade heart block, congestive heart failure, unstable angina, clinically significant bradycardia, hypokalemia, hypomagnesemia, ALT level greater than 3 times the upper limit of normal (ULN), AST level greater than 3 times the upper limit of normal (ULN), bilirubin greater than 2 x ULN, transaminase elevation, deficiency of pituitary hormones"
189,SOVALDI,adverse reactions,"Serious Symptomatic Bradycardia When Coadministered with Amiodarone and Another HCV Direct Acting Antiviral, fatigue, headache, nausea, insomnia, anemia, pancytopenia, severe depression, suicidal ideation, suicide, Hemoglobin <10, Hemoglobin <8.5, Neutrophils >=0.5 - <0.75, Neutrophils <0.5, Platelets >=25 - <50, Platelets <25, Total bilirubin elevation of more than 2.5*ULN, Creatine kinase elevation of greater than or equal to 10*ULN, Isolated, asymptomatic lipase elevation of greater than 3*ULN, Elevated total bilirubin (grade 3 or 4), Serious symptomatic bradycardia"
190,SOVALDI,warnings and precautions,"Serious symptomatic bradycardia, symptomatic bradycardia, pacemaker intervention, fatal cardiac arrest, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
191,OLYSIO,adverse reactions,"Serious Symptomatic Bradycardia When Co-administered with Sofosbuvir and Amiodarone, Hepatic Decompensation and Hepatic Failure, Photosensitivity, Rash, rash (including photosensitivity), pruritus, nausea, fatigue, headache, Myalgia, Dyspnea, Alkaline phosphatase elevation, Hyperbilirubinemia, insomnia, dizziness, diarrhea, Serious symptomatic bradycardia, hepatic decompensation, hepatic failure"
192,OLYSIO,warnings and precautions,"serious symptomatic bradycardia, hepatic decompensation, hepatic failure, fatal cases, photosensitivity reactions, rash, symptomatic bradycardia, pacemaker intervention, fatal cardiac arrest, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pain, confusion, memory problems, modest increases in bilirubin levels, markedly elevated bilirubin levels, fatigue, lack of appetite, nausea and vomiting, jaundice, discolored feces, liver transaminase increases, clinical signs and symptoms of hepatic decompensation, exaggerated sunburn reaction, burning, erythema, exudation, blistering, edema, severe rash, rash requiring discontinuation, mucosal signs, conjunctivitis, systemic symptoms, adverse reactions due to drug interactions"
193,PLEGRIDY,adverse reactions,"Hepatic Injury, Depression and Suicide, Seizures, Anaphylaxis and Other Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection site edema, Injection site warmth, Injection site hematoma, Injection site rash, Body temperature increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyl-transferase increased, Pruritus"
194,PLEGRIDY,warnings and precautions,"hepatic injury, signs and symptoms of hepatic injury, discontinuation of PLEGRIDY if hepatic injury occurs, depression, suicide, report any symptom of depression, suicidal ideation, discontinuation of PLEGRIDY if depression occurs, seizures, exercise caution with seizure disorder, anaphylaxis, other allergic reactions, serious allergic reactions, discontinue PLEGRIDY if a serious allergic reaction occurs, injection site reactions, change injection site, discontinuation of PLEGRIDY if necrosis, congestive heart failure, monitor worsening of cardiac symptoms, decreased peripheral blood counts, monitor complete blood counts, autoimmune disorders, discontinuation of PLEGRIDY if a new autoimmune disorder occurs, severe hepatic injury, hepatitis, autoimmune hepatitis, severe hepatic failure, asymptomatic elevation of hepatic transaminases, elevations in hepatic enzymes, increases in hepatic transaminases, elevations of alanine aminotransferate above 5 times the upper limit of normal, elevations of aspartate aminotransferase above 5 times the upper limit of normal, elevations of serum hepatic transaminases combined with elevated bilirubin, depression, suicidal ideation, suicide, serious events related to depression and suicidal ideation, injection site necrosis, injection site erythema, pain, pruritus, edema, severe injection site reactions, cardiovascular events, cardiomyopathy, cardiomyopathy with congestive heart failure, decreased white blood cell counts, decreased lymphocyte counts, decreased neutrophil counts, decreased platelet counts, severe thrombocytopenia, severe neutropenia, infections, bleeding, symptoms of anemia, myelosuppression, idiopathic thrombocytopenia, hyperthyroidism, hypothyroidism, autoimmune hepatitis."
195,VIBATIV,adverse reactions,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, diarrhea, taste disturbance, nausea, vomiting, foamy urine, death, serious adverse events, renal events, respiratory events, cardiac events, infectious events, treatment discontinuations, rash, pruritus, Rigors, Decreased appetite, metallic or soapy taste, renal adverse events, renal impairment, renal insufficiency, renal failure, acute renal failure, electrocardiogram QTc interval prolonged, septic shock, multi-organ failure, increased serum creatinine, Serious hypersensitivity reactions, anaphylactic reactions"
196,VIBATIV,boxed warnings,"increased mortality, Nephrotoxicity, New onset renal impairment, worsening renal impairment, Adverse developmental outcomes"
197,VIBATIV,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, infusion-related reactions, mild diarrhea, fatal colitis, QTc prolongation, renal adverse events, ""Red-man Syndrome""-like reactions, flushing of the upper body, urticaria, pruritus, rash, Clostridium difficile-associated diarrhea (CDAD), increased morbidity, mortality, overgrowth of nonsusceptible organisms, including fungi, superinfection"
198,KIT,adverse reactions,"injection site irritation, pain"
199,KIT,warnings and precautions,"hypersensitivity reactions, serious hypersensitivity reactions, risk for cancer, excessive radiation exposure"
200,HETLIOZ,adverse reactions,"headache, increased alanine aminotransferase, nightmares or unusual dreams, upper respiratory tract infection, urinary tract infection"
201,HETLIOZ,warnings and precautions,"May cause somnolence, impair the performance of activities requiring complete mental alertness"
202,VOTRIENT,adverse reactions,"diarrhea, hypertension, hair color changes (depigmentation), nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial and venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation and fistula, interstitial lung disease (ILD)/pneumonitis, reversible posterior leukoencephalopathy syndrome (RPLS), infection, increased toxicity with other cancer therapies, asthenia, abdominal pain, alopecia, chest pain, dysphonia, facial edema, palmar-plantar erythrodysesthesia (hand-foot syndrome), proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, skin hypopigmentation, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dyspepsia, dry skin, chills, vision blurred, nail disorder, albumin decreased, alkaline phosphatase increased, potassium increased, lipase elevations, pancreatitis, pneumothorax, bradycardia, retinal detachment/tear."
203,VOTRIENT,boxed warnings,"Severe hepatotoxicity, fatal hepatotoxicity"
204,VOTRIENT,warnings and precautions,"Increases in serum transaminase levels, bilirubin, Severe and fatal hepatotoxicity, Prolonged QT intervals, torsades de pointes, Cardiac dysfunction, congestive heart failure, decreased left ventricular ejection fraction (LVEF), Fatal hemorrhagic events, Arterial thromboembolic events, Venous thromboembolic events (VTE), fatal pulmonary emboli (PE), Thrombotic microangiopathy (TMA), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), Gastrointestinal perforation or fistula, Fatal perforation events, Interstitial lung disease (ILD)/pneumonitis, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Hypertension including hypertensive crisis, Hypothyroidism, Proteinuria, Serious infections (with or without neutropenia), some with fatal outcome, Increased Toxicity with Other Cancer Therapy, Increased Toxicity in Developing Organs, VOTRIENT can cause fetal harm"
205,JAKAFI,adverse reactions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Symptom Exacerbation Following Interruption or Discontinuation of Treatment with Jakafi, Non-Melanoma Skin Cancer, bruising, dizziness, headache, Urinary Tract Infections, Weight Gain, Flatulence, Herpes Zoster, newly occurring or worsening Grade 1 abnormalities in alanine transaminase (ALT), newly occurring or worsening Grade 1 abnormalities in aspartate transaminase (AST), newly occurring or worsening Grade 1 elevations in cholesterol, Abdominal Pain, Diarrhea, Fatigue, Pruritus, Dyspnea, Muscle Spasms, Nasopharyngitis, Constipation, Cough, Edema, Arthralgia, Asthenia, Epistaxis, Nausea, Weight gain, hypertension, urinary tract infections, Hypercholesterolemia, Elevated ALT, Elevated AST, Hypertriglyceridemia"
206,JAKAFI,warnings and precautions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Serious bacterial infections, mycobacterial infections, fungal infections, viral infections, Tuberculosis, Progressive multifocal leukoencephalopathy (PML), Herpes Zoster, Symptom Exacerbation Following Interruption or Discontinuation, fever, respiratory distress, hypotension, DIC (Disseminated Intravascular Coagulation), multi-organ failure, Non-Melanoma Skin Cancer, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma"
207,AKYNZEO,adverse reactions,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, AST > 3 x ULN and/or ALT > 3 x ULN with Total Bilirubin > ULN, AST > 10 x ULN and/or ALT > 10 x ULN with Total Bilirubin > ULN, AST > 3 x ULN and/or ALT > 3 x ULN with Total Bilirubin >= 2 x ULN"
208,AKYNZEO,warnings and precautions,"Hypersensitivity reactions, anaphylaxis, Serotonin syndrome, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea"
209,VIEKIRA,adverse reactions,"Increased Risk of ALT Elevations, fatigue, nausea, pruritus, other skin reactions, insomnia, asthenia, serious adverse event (SAE), rash, erythema, eczema, rash maculo-papular, rash macular, dermatitis, rash papular, skin exfoliation, rash pruritic, rash erythematous, rash generalized, dermatitis allergic, dermatitis contact, exfoliative rash, photosensitivity reaction, psoriasis, skin reaction, ulcer, urticaria, dyspnea, Stevens Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), erythema multiforme (EM), drug rash with eosinophilia and systemic symptoms (DRESS), serum ALT levels greater than 5 times the upper limit of normal (ULN), clinically relevant ALT elevations, bilirubin elevations, anemia/decreased hemoglobin, headache, cough, irritability, ocular icterus, hyperbilirubinemia, jaundice, diarrhea, muscle spasms, hypersensitivity reactions (including angioedema)"
210,VIEKIRA,warnings and precautions,"ALT elevations, loss of therapeutic effect of VIEKIRA PAK, development of resistance, clinically significant adverse reactions from greater exposures of concomitant drugs or components of VIEKIRA PAK, onset of fatigue, weakness, lack of appetite, nausea and vomiting, jaundice, discolored feces, liver inflammation, increasing conjugated bilirubin, alkaline phosphatase, INR elevation, HIV-1 protease inhibitor resistance-associated substitutions"
211,PERJETA,adverse reactions,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions/Anaphylaxis, diarrhea, alopecia, neutropenia, nausea, fatigue, rash, peripheral neuropathy, vomiting, thrombocytopenia, anemia, asthenia, febrile neutropenia, leukopenia, Edema peripheral, Mucosal inflammation, Pyrexia, Nail disorder, Pruritus, Dry skin, Constipation, Stomatitis, Headache, Dysgeusia, Dizziness, Myalgia, Arthralgia, Upper respiratory tract infection, Nasopharyngitis, Dyspnea, Decreased appetite, Lacrimation increased, Insomnia, Paronychia, Pleural effusion, hypersensitivity, ALT increased, hypokalemia, Cough, Epistaxis, Oropharyngeal pain, Palmar-Plantar Erythrodysaesthesia Syndrome, Dyspepsia."
212,PERJETA,boxed warnings,"LEFT VENTRICULAR DYSFUNCTION, CHF, decreased LVEF, subclinical cardiac failure, clinical cardiac failure, EMBRYO-FETAL TOXICITY, embryo-fetal death, birth defects, oligohydramnios, delayed renal development"
213,PERJETA,warnings and precautions,"Left Ventricular Dysfunction, Embryo-fetal toxicity, Infusion-Related Reactions, Hypersensitivity Reactions/Anaphylaxis, oligohydramnios, delayed fetal kidney development, embryo-fetal death, pyrexia, chills, fatigue, headache, asthenia, hypersensitivity, vomiting, dysgeusia, myalgia, anaphylaxis"
214,KEYTRUDA,adverse reactions,"immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, renal failure, immune-mediated nephritis, other immune-mediated adverse reactions, infusion-related reactions, fatigue, cough, nausea, pruritus, rash, decreased appetite, constipation, arthralgia, diarrhea, pain, serious adverse reactions, renal failure, dyspnea, pneumonia, cellulitis, peripheral edema, chills, pyrexia, vomiting, abdominal pain, vitiligo, pain in extremity, myalgia, back pain, headache, dizziness, anemia, insomnia, upper respiratory tract infection, sepsis, hyperglycemia, hyponatremia, hypoalbuminemia, hypertriglyceridemia, increased aspartate aminotransferase, hypocalcemia"
215,KEYTRUDA,warnings and precautions,"pneumonitis, colitis, hepatitis, hypophysitis, hyperthyroidism, hypothyroidism, Type 1 diabetes mellitus, nephritis, infusion-related reactions, embryofetal toxicity, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, severe dermatitis, bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis"
216,MYALEPT,adverse reactions,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening of metabolic control"
217,MYALEPT,boxed warnings,"anti-metreleptin antibodies with neutralizing activity, inhibition of endogenous leptin action, loss of MYALEPT efficacy, severe infection, worsening metabolic control, T-cell lymphoma"
218,MYALEPT,warnings and precautions,"Anti-metreleptin antibodies with neutralizing activity, T-cell lymphoma, Hypoglycemia, Autoimmunity, Hypersensitivity reactions (e.g., anaphylaxis, urticaria or generalized rash), Benzyl Alcohol Toxicity, severe infections, loss of efficacy, increases in HbA1c, increases in triglycerides, excessive weight gain, development of glucose intolerance, diabetes mellitus, peripheral T-cell lymphoma, severe bone marrow abnormalities, anaplastic large cell lymphoma, leukopenia, neutropenia, lymphadenopathy, progression of autoimmune hepatitis, membranoproliferative glomerulonephritis, massive proteinuria, renal failure"
219,TRADJENTA,adverse reactions,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, severe hypoglycemia, acute pancreatitis, fatal pancreatitis, anaphylaxis, exfoliative skin conditions, severe and disabling arthralgia, rash, mouth ulceration, stomatitis"
220,TRADJENTA,warnings and precautions,"acute pancreatitis, fatal pancreatitis, hypoglycemia, serious hypersensitivity reactions, anaphylaxis, angioedema, exfoliative skin conditions, severe and disabling arthralgia"
221,BRINTELLIX,adverse reactions,"Hypersensitivity, Clinical Worsening and Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, nausea, constipation, vomiting, Diarrhea, Dry mouth, Flatulence, Dizziness, Abnormal dreams, Pruritus, Sexual Dysfunction, headache, muscle tension, mood swings, sudden outbursts of anger, runny nose, vertigo, dyspepsia, dysgeusia, flushing"
222,BRINTELLIX,boxed warnings,"suicidal thoughts and behaviors in children, adolescents, and young adults, worsening of depression, emergence of suicidal thoughts and behaviors"
223,BRINTELLIX,warnings and precautions,"Serotonin Syndrome, abnormal bleeding, Activation of Mania/Hypomania, Angle Closure Glaucoma, Hyponatremia, clinical worsening, suicide risk, suicidal ideation, suicidal behavior, worsening of depression, emergence of suicidality, unusual changes in behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), gastrointestinal bleeding, ecchymosis, hematoma, epistaxis, petechiae, life-threatening hemorrhages, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death"
224,AUBAGIO,adverse reactions,"Hepatotoxicity, Bone Marrow Effects, Immunosuppression Potential, Infections, Peripheral Neuropathy, Skin Reactions, Increased Blood Pressure, Respiratory Effects, headache, diarrhea, nausea, alopecia, increase in ALT, Paresthesia, Arthralgia, Neutropenia, Hypertension, Cardiovascular deaths, Acute Renal Failure, Hypophosphatemia"
225,AUBAGIO,boxed warnings,"hepatotoxicity, fatal liver failure, severe liver injury, drug induced liver injury, severe hepatic impairment, elevated serum transaminases, major birth defects"
226,AUBAGIO,warnings and precautions,"severe liver injury, fatal liver failure, liver dysfunction, elevated serum transaminases, ALT greater than three times the ULN, jaundice, hepatotoxicity, decreased WBC count, signs and symptoms of infection, serious infection, peripheral neuropathy, polyneuropathy, mononeuropathy, carpal tunnel syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, increased blood pressure, hypertension, interstitial lung disease, worsening of pre-existing interstitial lung disease, cough, dyspnea, fever, serious pancytopenia, agranulocytosis, thrombocytopenia, serious infections, klebsiella pneumonia sepsis, Pneumocystis jiroveci pneumonia, aspergillosis, cytomegalovirus hepatitis reactivation, tuberculosis"
227,POMALYST,adverse reactions,"Fetal Risk, Venous and Arterial Thromboembolism, Hematologic Toxicity, Hepatotoxicity, Hypersensitivity Reactions, Dizziness and Confusional State, Neuropathy, Risk of Second Primary Malignancies, Tumor Lysis Syndrome, fatigue and asthenia, neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper-respiratory tract infections, back pain, pyrexia, Neutropenia, Thrombocytopenia, Leukopenia, Febrile neutropenia, Lymphopenia, Edema peripheral, Chills, Nausea, Vomiting, Musculoskeletal chest pain, Muscle spasms, Arthralgia, Muscular weakness, Bone pain, Musculoskeletal pain, Pain in extremity, Pneumonia, Urinary tract infection, Sepsis, Decreased appetite, Hypercalcemia, Hypokalemia, Hyperglycemia, Hyponatremia, Dehydration, Hypocalcemia, Cough, Epistaxis, Productive cough, Oropharyngeal pain, Dizziness, Peripheral neuropathy, Headache, Tremor, Rash, Pruritus, Dry skin, Hyperhidrosis, Night sweats, Blood creatinine increased, Weight decreased, Weight increased, Anxiety, Confusional state, Insomnia, Renal failure, Neutrophil count decreased, Platelet count decreased, White blood cell count decreased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Lymphocyte count decreased, Femur fracture, Pelvic pain, Myocardial infarction, Atrial fibrillation, Angina pectoris, Cardiac failure congestive, Vertigo, Abdominal pain, General physical health deterioration, Non-cardiac chest pain, Multi-organ failure, Hyperbilirubinemia, Pneumocystis jiroveci pneumonia, Respiratory syncytial virus infection, Neutropenic sepsis, Bacteremia, Pneumonia respiratory syncytial viral, Cellulitis, Urosepsis, Septic shock, Clostridium difficile colitis, Pneumonia streptococcal, Lobar pneumonia, Viral infection, Lung infection, Hemoglobin decreased, Fall, Compression fracture, Spinal compression fracture, Hyperkalemia, Failure to thrive, Depressed level of consciousness, Syncope, Mental status change, Urinary retention, Hyponatremia, Interstitial lung disease, Pulmonary embolism, Respiratory failure, Bronchospasm, Hypotension, Pancytopenia, allergic reactions, angioedema, urticaria, elevated liver enzymes, hepatic failure."
228,POMALYST,boxed warnings,"severe birth defects, embryo-fetal death, Deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, stroke"
229,POMALYST,warnings and precautions,"Neutropenia, Hematologic Toxicity, Hepatotoxicity, Hepatic failure, fatalities, Angioedema, severe dermatologic reactions, Tumor Lysis Syndrome (TLS), Venous thromboembolic events, deep venous thrombosis, pulmonary embolism, arterial thromboembolic events, myocardial infarction, stroke, anemia, thrombocytopenia, febrile neutropenia, Elevated levels of alanine aminotransferase, Elevated levels of bilirubin, skin exfoliation, bullae, Dizziness, Confusional State, Neuropathy, peripheral neuropathy, acute myelogenous leukemia, Second Primary Malignancies"
230,SURFAXIN,adverse reactions,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, apnea, intraventricular hemorrhage, periventricular leukomalacia, acquired sepsis, patent ductus arteriosus, retinopathy of prematurity, necrotizing enterocolitis, pulmonary air leak, pulmonary interstitial emphysema, pneumothorax, pulmonary hemorrhage, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, hypotension, respiratory acidosis, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia/decreased oxygen saturation, pneumothorax (repeated), hypotension (repeated), pulmonary embolism"
231,SURFAXIN,warnings and precautions,"Acute Changes in Lung Compliance, bradycardia, oxygen desaturation, reflux of SURFAXIN into the endotracheal tube, airway/ETT obstruction, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, pneumothorax, hypotension, pulmonary embolism"
232,ARZERRA,adverse reactions,"Infusion reactions, Hepatitis B Virus Reactivation, Hepatitis B Virus Infection, Progressive Multifocal Leukoencephalopathy, Tumor Lysis Syndrome, Cytopenias, neutropenia, pneumonia, pyrexia, cough, diarrhea, anemia, fatigue, dyspnea, rash, nausea, bronchitis, upper respiratory tract infections, infections, sepsis, Asthenia, Headache, Leukopenia, Herpes simplex, Lower respiratory tract infection, Arthralgia, Upper abdominal pain, neutropenic sepsis, agranulocytosis, prolonged neutropenia, late-onset neutropenia, Edema peripheral, Back pain, Chills, Nasopharyngitis, Urticaria, Insomnia, Herpes zoster, Hyperhidrosis, Hypertension, Hypotension, Muscle spasms, Sinusitis, Tachycardia, bacterial infections, viral infections, fungal infections, Grade 3 or greater infections, fatal infections, Grade 3 or greater neutropenia, Grade 4 neutropenia, new onset Grade 4 neutropenia, Cardiac arrest, Stevens-Johnson syndrome, porphyria cutanea tarda"
233,ARZERRA,boxed warnings,"Hepatitis B Virus Reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML)"
234,ARZERRA,warnings and precautions,"infusion reactions, bronchospasm, dyspnea, laryngeal edema, pulmonary edema, flushing, hypertension, hypotension, syncope, cardiac events, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, back pain, abdominal pain, pyrexia, rash, urticaria, angioedema, cytokine release syndrome, anaphylactoid/anaphylactic reactions, Tumor Lysis Syndrome (TLS), neutropenia, anemia, thrombocytopenia, late-onset neutropenia, prolonged neutropenia, Hepatitis B Virus (HBV) reactivation, fulminant hepatitis, hepatic failure, death, hepatitis, increase in transaminase levels, increase in bilirubin levels, liver failure, Progressive Multifocal Leukoencephalopathy (PML), hospitalization due to TLS, pancytopenia, agranulocytosis, fatal neutropenic sepsis, Grade 3 or 4 late-onset neutropenia, prolonged neutropenia"
235,ESBRIET,adverse reactions,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, nausea, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastro-esophageal reflux disease, sinusitis, insomnia, weight decreased, arthralgia, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain, Agranulocytosis, Angioedema, Bilirubin increased"
236,ESBRIET,warnings and precautions,"Elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, Photosensitivity, rash, Nausea, vomiting, diarrhea, dyspepsia, gastro-esophageal reflux disease, abdominal pain, Increases in ALT and AST >3 * ULN, concomitant elevations in bilirubin, Elevations >=10 * ULN in ALT or AST, severe liver injury, photosensitivity reactions, gastrointestinal events"
237,ACTEMRA,all-concat,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforation, infusion reactions, hypertension, skin reactions, rash, pruritus, urticaria, anaphylaxis, neutropenia, thrombocytopenia, elevated liver enzymes, liver enzyme abnormalities, AST increased, ALT increased, lipids, elevated lipids, total cholesterol increased, LDL increased, HDL increased, LDL/HDL ratio increased, ApoB/ApoA1 ratio, immunogenicity, anti-tocilizumab antibodies, malignancies, dizziness, bronchitis, mouth ulceration, abdominal pain upper, gastritis, transaminase increased, oral herpes simplex, stomatitis, gastric ulcer, weight increased, total bilirubin increased, leukopenia, edema peripheral, dyspnea, cough, conjunctivitis, nephrolithiasis, hypothyroidism, injection site reactions, erythema, pain, hematoma, macrophage activation syndrome, angioedema, arthralgia, diarrhea, epigastric discomfort, Stevens-Johnson Syndrome, fatal anaphylaxis, active tuberculosis, invasive fungal infections, candidiasis, aspergillosis, pneumocystis, bacterial infections, viral infections, viral reactivation, hepatitis B reactivation, gastrointestinal perforation, demyelinating disorders, multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, active hepatic disease, hepatic impairment."
238,ADEMPAS,all-concat,"Embryo-Fetal Toxicity, Hypotension, Bleeding, headache, dyspepsia/gastritis, dizziness, nausea, diarrhea, hypotension, vomiting, anemia, gastroesophageal reflux, constipation, palpitations, nasal congestion, epistaxis, dysphagia, abdominal distension, peripheral edema, Symptomatic hypotension, Pulmonary edema, serious bleeding, hemoptysis, vaginal hemorrhage, catheter site hemorrhage, subdural hematoma, hematemesis, intra-abdominal hemorrhage, Pulmonary Veno-Occlusive Disease"
239,AKYNZEO,all-concat,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, hypersensitivity reactions, anaphylaxis, serotonin syndrome, agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, nausea, vomiting, diarrhea"
240,ANORO,all-concat,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, worsening of narrow-angle glaucoma, worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough, dry mouth, dyspepsia, abdominal pain, gastroesophageal reflux disease, vomiting, musculoskeletal chest pain, chest discomfort, asthenia, atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, pruritus, rash, conjunctivitis, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus"
241,ARCALYST,all-concat,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, injection-site reaction (ISR), upper respiratory infection, nausea, diarrhea, abdominal pain upper, cough, hypoesthesia, stomach discomfort, urinary tract infection, erythema, swelling, pruritis, mass, bruising, inflammation, pain, edema, dermatitis, discomfort, urticaria, vesicles, warmth, hemorrhage, transient neutropenia, cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase, serious infections, hypersensitivity reactions, reactivation of latent tuberculosis, malignancies, changes in lipid profiles"
242,ARZERRA,all-concat,"Infusion reactions, Hepatitis B Virus Reactivation, Hepatitis B Virus Infection, Progressive Multifocal Leukoencephalopathy, Tumor Lysis Syndrome, Cytopenias, neutropenia, pneumonia, pyrexia, cough, diarrhea, anemia, fatigue, dyspnea, rash, nausea, bronchitis, upper respiratory tract infections, infections, sepsis, asthenia, headache, leukopenia, herpes simplex, lower respiratory tract infection, arthralgia, upper abdominal pain, hematologic laboratory abnormalities, leukopenia, lymphopenia, neutropenic sepsis, agranulocytosis, prolonged neutropenia, late-onset neutropenia, edema peripheral, back pain, chills, nasopharyngitis, sepsis, urticaria, insomnia, herpes zoster, hyperhidrosis, hypertension, hypotension, muscle spasms, sinusitis, tachycardia, cardiac arrest, Stevens-Johnson syndrome, porphyria cutanea tarda, fulminant hepatitis, hepatic failure, death, bronchospasm, dyspnea, laryngeal edema, pulmonary edema, flushing, hypertension, hypotension, syncope, cardiac events, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, back pain, abdominal pain, pyrexia, urticaria, angioedema, cytokine release syndrome, anaphylactoid/anaphylactic reactions, pancytopenia, agranulocytosis, fatal neutropenic sepsis, Grade 3 or 4 late-onset neutropenia, prolonged neutropenia, thrombocytopenia, anemia."
243,ASCLERA,all-concat,"mild local reactions at the site of injection, Injection site haematoma, Injection site irritation, Injection site discoloration, Injection site pain, Injection site pruritus, Injection site warmth, Neovascularisation, Injection site thrombosis, Anaphylactic shock, angioedema, urticaria generalized, asthma, Cerebrovascular accident, migraine, paresthesia (local), loss of consciousness, confusional state, dizziness, Cardiac arrest, palpitations, Deep vein thrombosis, pulmonary embolism, syncope vasovagal, circulatory collapse, vasculitis, Dyspnea, Skin hyperpigmentation, dermatitis allergic, hypertrichosis (in the area of sclerotherapy), Injection site necrosis, pyrexia, hot flush, Nerve injury, tissue necrosis, anaphylactic reactions, severe allergic reactions, Severe necrosis, ischemia, gangrene, pain"
244,AUBAGIO,all-concat,"hepatotoxicity, bone marrow effects, immunosuppression potential, infections, peripheral neuropathy, skin reactions, increased blood pressure, respiratory effects, headache, diarrhea, nausea, alopecia, increase in ALT, paresthesia, arthralgia, neutropenia, hypertension, cardiovascular deaths, acute renal failure, hypophosphatemia, severe liver injury, fatal liver failure, drug induced liver injury, elevated serum transaminases, jaundice, hypophosphatemia, white blood cell count decrease, risk of infection, tuberculosis screening, vaccination, malignancy, Stevens-Johnson syndrome, toxic epidermal necrolysis, interstitial lung disease, concomitant use with immunosuppressive or immunomodulating therapies"
245,BANZEL,all-concat,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, influenza, nasopharyngitis, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, Stevens-Johnson syndrome, serious skin rashes with mucosal involvement, depression, worsening depression, unusual changes in mood or behavior, coordination abnormalities, gait disturbances, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, anemia, lymphadenopathy, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, increased appetite, pneumonia, decreased weight, gastroenteritis, nasal congestion, pneumonia aspiration."
246,BELSOMRA,all-concat,"CNS depressant effects, daytime impairment, abnormal thinking, behavioral changes, worsening of Depression, Suicidal ideation, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, somnolence, diarrhea, dry mouth, upper respiratory tract infection, headache, dizziness, abnormal dreams, cough, impaired alertness, motor coordination impairment, impaired driving, falling asleep while driving, daytime somnolence, CNS depressant effects, amnesia, anxiety, hallucinations, neuro-psychiatric symptoms, ""sleep-driving"", complex behaviors (preparing and eating food, making phone calls, having sex), suicidal ideation, worsening of depression, suicidal thoughts, actions (including completed suicides), compromised respiratory function, vivid and disturbing perceptions, leg weakness"
247,BELVIQ,all-concat,"Serotonin Syndrome or NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, headache, dizziness, fatigue, nausea, dry mouth, constipation, back pain, cough, diarrhea, vomiting, upper respiratory tract infection, nasopharyngitis, urinary tract infection, musculoskeletal pain, oropharyngeal pain, sinus congestion, rash, toothache, peripheral edema, seasonal allergy, gastroenteritis, worsening of diabetes mellitus, decreased appetite, muscle spasms, anxiety, insomnia, stress, depression, hypertension, blurred vision, dry eye, visual impairment, visual disorders, conjunctival infections, irritations, inflammations, ocular sensation disorders, cataract conditions, euphoria, hallucination, dissociation, suicidal ideation, lymphocyte counts below normal, neutrophil counts low, hemoglobin below normal, eye disorders, regurgitant cardiac valve disease, aortic insufficiency, mitral insufficiency, valvular regurgitation, priapism, bradycardia, leukopenia, lymphopenia, neutropenia, decreased white cell count, anemia, decreases in hemoglobin and hematocrit, galactorrhea, gynecomastia, prolactinoma, pulmonary hypertension."
248,BRILINTA,all-concat,"Bleeding, Dyspnea, Intracranial hemorrhage, Fatal/Life-threatening, Fatal, Major, Minor bleed, Major fatal/life-threatening, Non-CABG related bleeds, CABG-related bleeding, Dizziness, Nausea, Bradycardia, Syncope, Pre-syncope, Loss of consciousness, Serum Uric Acid, Gout, Serum Creatinine, Renal failure, Toxic nephropathy, Oliguria, Severe Hepatic Impairment"
249,BRINTELLIX,all-concat,"Hypersensitivity, Clinical Worsening and Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, nausea, constipation, vomiting, diarrhea, dry mouth, flatulence, dizziness, abnormal dreams, pruritus, headache, muscle tension, mood swings, sudden outbursts of anger, runny nose, vertigo, dyspepsia, dysgeusia, flushing, suicidal thoughts and behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, sexual dysfunction, treatment-emergent sexual dysfunction, angle closure glaucoma, syndrome of inappropriate antidiuretic hormone secretion (SIADH), hallucination, syncope, seizure, coma, respiratory arrest, death"
250,CAPRELSA,all-concat,"QT Prolongation, Torsades de Pointes, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, diarrhea/colitis, rash, acneiform dermatitis, nausea, headache, upper respiratory tract infections, decreased appetite, abdominal pain, asthenia, fatigue, pyrexia, elevated creatinine, QT prolongation, Vomiting, Dyspepsia, Dry Mouth, Dermatitis Acneiform/Acne, Dry Skin, Photosensitivity Reaction, Pruritus, Nail abnormalities, Alopecia, Hypertension/Hypertensive Crisis/Accelerated Hypertension, Headache, Dysgeusia, Fatigue, Upper Respiratory Tract Infections, Decreased Appetite, Hypocalcemia, ECG QT Prolonged, Corneal Abnormalities, Blurred Vision, Proteinuria, Depression, Muscle Spasms, pancreatitis, heart failure, intestinal perforation, Grade 1-2 bleeding events, Hypocalcemia, ALT Increased, Hypoglycemia, Creatinine Increased, Hypomagnesemia, Neutropenia, Thrombocytopenia, ventricular tachycardia, sudden deaths, severe skin reactions, pneumonitis, severe hemorrhage, severe ischemic cerebrovascular event, subcortical vasogenic edema, seizures, visual disturbances, confusion, altered mental function, embryotoxic, fetotoxic, teratogenic, adverse effects on female fertility, embryofetal development, postnatal development of pups."
251,CYRAMZA,all-concat,"Hemorrhage, Arterial Thromboembolic Events, Hypertension, Infusion-Related Reactions, Gastrointestinal Perforation, Impaired Wound Healing, Reversible Posterior Leukoencephalopathy Syndrome, Proteinuria Including Nephrotic Syndrome, Thyroid Dysfunction, anemia, intestinal obstruction, red blood cell transfusions, hyponatremia, headache, neutropenia, epistaxis, rash, arterial thromboembolic events, fatigue, diarrhea, stomatitis/mucosal inflammation, decreased appetite, febrile neutropenia, granulocyte colony-stimulating factors, thrombocytopenia, gastrointestinal hemorrhage events, fatigue/asthenia, peripheral edema, hypoalbuminemia, lacrimation increased, palmar-plantar erythrodysesthesia syndrome, sepsis, gastrointestinal perforations, febrile neutropenia, pneumonia, hypothyroidism, embryofetal toxicity"
252,DALIRESP,all-concat,"Psychiatric Events Including Suicidality, Weight Decrease, diarrhea, weight decrease, nausea, headache, back pain, influenza, insomnia, dizziness, decreased appetite, diarrhea, atrial fibrillation, lung cancer, prostate cancer, acute pancreatitis, acute renal failure, abdominal pain, dyspepsia, gastritis, vomiting, rhinitis, sinusitis, urinary tract infection, muscle spasms, tremor, anxiety, depression, hypersensitivity reactions including angioedema, urticaria, rash, Acute bronchospasm, suicidal ideation and behavior, including completed suicide"
253,EDURANT,all-concat,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, depressive disorders, headache, insomnia, rash, psychiatric disorders, abdominal pain, nausea, vomiting, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, Increased Creatinine, Increased AST, Increased ALT, Increased Total Bilirubin, Increased Total Cholesterol (fasted), Increased LDL Cholesterol (fasted), Increased Triglycerides (fasted), adrenal insufficiency, Serum Creatinine increases, Serum Lipids changes, hepatic enzyme elevation, nephrotic syndrome, Severe skin and hypersensitivity reactions, DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), redistribution/accumulation of body fat, immune reconstitution syndrome, autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barre syndrome)."
254,EFFIENT,all-concat,"Bleeding, life-threatening bleeding, fatal bleeding, Thrombotic thrombocytopenic purpura, TIMI Major or Minor bleeding, TIMI Major bleeding, Life-threatening, Fatal, Symptomatic intracranial hemorrhage (ICH), Requiring inotropes, Requiring surgical intervention, Requiring transfusion (>=4 units), TIMI Minor bleeding, Non-CABG-Related TIMI Major or Minor Bleeding, CABG-Related Bleeding, Hemorrhagic events, epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade, retinal hemorrhage, severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, Thrombocytopenia, Hypersensitivity reactions including anaphylaxis, active pathological bleeding, transient ischemic attack, stroke, increased risk of fatal and intracranial bleeding, urgent coronary artery bypass graft surgery (CABG), body weight <60 kg, propensity to bleed, concomitant use of medications that increase the risk of bleeding, hypotensive, coronary angiography, percutaneous coronary intervention (PCI), other surgical procedures, cardiovascular events, CABG-related bleeding, Discontinuation of Effient, stent thrombosis, myocardial infarction, death, Thrombotic Thrombocytopenic Purpura (TTP), microangiopathic hemolytic anemia, neurological findings, renal dysfunction, fever, Hypersensitivity Including Angioedema."
255,EGRIFTA,all-concat,"hypersensitivity, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, irritation, swelling, hemorrhage, discontinuations as a result of adverse reactions, Musculoskeletal and connective tissue disorders, General disorders and administration site conditions, Nervous system disorders, Gastrointestinal disorders, Cardiac disorders, Psychiatric disorders, Skin and subcutaneous tissue disorders, Vascular disorders, Injury, poisoning and procedural complications, Investigations, Blood creatine phosphokinase increased, diabetes, Immunogenicity, anti- EGRIFTA (r) antibodies, anti-tesamorelin IgG antibodies, Cross-reactivity to endogenous growth hormone-releasing hormone (GHRH), Neutralizing antibodies to tesamorelin and hGHRH, Neoplasms, Elevated IGF-1, Fluid retention, Glucose intolerance, Hypersensitivity reactions, Injection site reactions, Acute critical illness, Paresthesia, Hypoesthesia, Nausea, Vomiting, Dyspepsia, Abdominal pain upper, Palpitations, Depression, Rash, Night sweats, Hypertension, Muscle strain, Pain in extremity, Myalgia, Musculoskeletal pain, Musculoskeletal stiffness, Joint stiffness, Muscle spasms, Joint swelling, Injection site pain, Injection site irritation, Chest pain, Injection site rash, Neuropathy peripheral, Insomnia, Urticaria, Hot flush"
256,ELELYSO,all-concat,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, Type III immune-mediated fixed drug eruption, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, mild throat irritation, chest discomfort, anaphylaxis, angioedema, erythema, cough, chest tightness, throat irritation"
257,ELLA,all-concat,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, acne, lower abdominal pain, altered menstrual cycle, delayed menses, intermenstrual bleeding"
258,ENTYVIO,all-concat,"Infusion-Related Reactions, Hypersensitivity Reactions, Infections, Progressive Multifocal Leukoencephalopathy, Liver Injury, nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, pain in extremities, anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, increased blood pressure and heart rate, infusion-related reaction, dizziness, vomiting, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, hepatitis, malignancies, colon cancer, transitional cell carcinoma, breast cancer, carcinoid tumor of the appendix, squamous cell carcinoma, B-cell lymphoma, malignant hepatic neoplasm, malignant lung neoplasm, malignant melanoma, lung cancer of primary neuroendocrine carcinoma, renal cancer, elevations of transaminase and/or bilirubin, jaundice, serious liver injury, death, liver transplant, secondary transmission of infection by live vaccines, lower rates of protective immunity to Hepatitis B virus, lower seroconversion rates and anti-cholera titers, latent pulmonary tuberculosis, pulmonary tuberculosis, extrapulmonary manifestations."
259,ERIVEDGE,all-concat,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia, embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, severe midline defects, missing digits, irreversible malformations"
260,ESBRIET,all-concat,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, nausea, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastro-esophageal reflux disease, sinusitis, insomnia, weight decreased, arthralgia, photosensitivity reaction, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain, Agranulocytosis, Angioedema, Bilirubin increased, ALT elevations, AST elevations, transaminase elevations"
261,FOLOTYN,all-concat,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, thrombocytopenia, nausea, fatigue, pyrexia, sepsis, febrile neutropenia, dehydration, dyspnea, stomatitis, mucosal inflammation, anemia, constipation, edema, cough, epistaxis, vomiting, neutropenia, diarrhea, anorexia, hypokalemia, rash, pruritus, pharyngolaryngeal pain, liver function test abnormal, abdominal pain, pain in extremity, back pain, leukopenia, night sweats, asthenia, tachycardia, upper respiratory tract infection, cardiopulmonary arrest, pancytopenia, toxic epidermal necrolysis"
262,FYCOMPA,all-concat,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness and Gait Disturbance, Somnolence and Fatigue, Falls, dizziness, somnolence, fatigue, irritability, falls, nausea, weight gain, vertigo, ataxia, headache, vomiting, contusion, abdominal pain, anxiety, aggression, anger, blurred vision, dysarthria, balance disorder, gait disturbance, weight gain, cough, upper respiratory tract infection, hypersomnia, euphoric mood, confusional state, hyponatremia, limb injury, mood altered, arthralgia, asthenia, contusion, memory impairment, musculoskeletal pain, oropharyngeal pain, paraesthesia, peripheral edema, skin laceration, urinary tract infection, ligament sprain, rash, hostility, aggression-related adverse reactions, belligerence, affect lability, agitation, physical assault, homicidal ideation and/or threat, paranoia, mental status changes, disorientation/confusional state, delusion, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), aggression, hostility, irritability, anger, homicidal ideation and threats, suicidal thoughts or behavior, depression, dizziness, vertigo, ataxia, balance disorder, abnormal coordination, fatigue, asthenia, lethargy, falls, head injuries, bone fracture, seizure frequency increase."
263,GATTEX,all-concat,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, cholecystitis, cholangitis, cholelithiasis, pancreatitis, congestive heart failure, altered mental status"
264,GAZYVA,all-concat,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Urinary tract infection, Back pain, Nasopharyngitis, Constipation, Lymphopenia, Leukopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Musculoskeletal disorders, Liver enzyme elevations, Hemorrhagic events, Fatal hemorrhagic events, Worsening of Pre-existing Cardiac Conditions, Fulminant hepatitis, Hepatic failure, Death, Acute renal failure, Hyperkalemia, Hypocalcemia, Hyperuricemia, Hyperphosphatemia, Serious bacterial infections, Fungal infections, New or reactivated viral infections, Fatal infections, Late-onset neutropenia, Prolonged neutropenia, Acute thrombocytopenia, Fatal cardiac events"
265,HARVONI,all-concat,"fatigue, headache, nausea, diarrhea, insomnia, Bilirubin elevations, Lipase Elevations, Creatine Kinase elevations, Serious symptomatic bradycardia, fatal cardiac arrest, cases requiring pacemaker intervention, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
266,HETLIOZ,all-concat,"headache, increased alanine aminotransferase, nightmares or unusual dreams, upper respiratory tract infection, urinary tract infection, somnolence"
267,ICLUSIG,all-concat,"Vascular Occlusion, Heart Failure, Hepatotoxicity, Hypertension, Pancreatitis, Neuropathy, Ocular Toxicity, Hemorrhage, Fluid Retention, Cardiac Arrhythmias, Myelosuppression, Arterial ischemia, Cardiac Failure, Abdominal pain, Constipation, Nausea, Diarrhea, Vomiting, Oral mucositis, GI hemorrhage, Febrile neutropenia, Sepsis, Pneumonia, Urinary tract infection, Upper respiratory tract infection, Nasopharyngitis, Cellulitis, Headache, Peripheral neuropathy, Dizziness, Pleural effusion, Cough, Dyspnea, Rash and related conditions, Dry skin, Arthralgia, Myalgia, Pain in extremity, Back pain, Muscle spasms, Bone pain, Fatigue or asthenia, Pyrexia, Edema, peripheral, Pain, Chills, Decreased appetite, Weight decreased, Insomnia, Arterial ischemic event, Cardiovascular, Cerebrovascular, Peripheral vascular, CNS hemorrhage, Gastrointestinal hemorrhage, Effusions, Atrial fibrillation, Venous thromboembolism, Thrombocytopenia, Anemia, Lymphopenia, Leukopenia, ALT increased, AST increased, Alkaline phosphatase increased, Albumin decreased, Bilirubin increased, Lipase increased, Amylase increased, Glucose increased, Phosphorus decreased, Calcium decreased, Sodium decreased, Glucose decreased, Potassium decreased, Potassium increased, Sodium increased, Bicarbonate decreased, Creatinine increased, Calcium increased, Triglycerides increased, Tumor Lysis Syndrome, Compromised Wound Healing and Gastrointestinal Perforation, Embryo-Fetal Toxicity"
268,IMPAVIDO,all-concat,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, anemia, lymphadenopathy, abdominal distension, constipation, dysphagia, flatulence, fatigue, abscess, cellulitis, ecthyma, paresthesia, testicular pain, testicular swelling, urticaria, rash, pyoderma, thrombocytopenia, agranulocytosis, melena, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis, fetal death, teratogenicity, impaired fertility, reversible follicular atresia, diestrus, reduced viable sperm counts, testicular atrophy."
269,ISTODAX,all-concat,"Myelosuppression, Infection, Electrocardiographic Changes, Tumor Lysis Syndrome, neutropenia, lymphopenia, thrombocytopenia, infections, nausea, fatigue, vomiting, anorexia, anemia, ECG T-wave changes, Asthenia/Fatigue, Hypomagnesemia, Diarrhea, Pyrexia, Dysgeusia, Constipation, Hypotension, Pruritus, Hypokalemia, Dermatitis/Exfoliative dermatitis, Hypocalcemia, Leukopenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hypoalbuminemia, Electrocardiogram ST-T wave changes, Hyperglycemia, Hyponatremia, Hypermagnesemia, Hypophosphatemia, Hyperuricemia, sepsis, supraventricular arrhythmia, central line infection, edema, ventricular arrhythmia, dehydration, catheter related infection, cardiopulmonary failure, acute renal failure, myocardial ischemia, acute respiratory distress syndrome, QT prolongation, Gastrointestinal disorders, Abdominal pain, Stomatitis, General disorders and administration site conditions, Chills, Edema peripheral, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Headache, Respiratory, thoracic and mediastinal disorders, Cough, Investigations, Weight decreased, Cardiac disorders, Tachycardia, pneumonia, cellulitis, deep vein thrombosis, febrile neutropenia, chest pain, pulmonary embolism, hyperbilirubinemia, hypoxia, hypersensitivity, syncope, pneumonitis, packed red blood cell transfusion, platelet transfusion, hepatitis B virus infection, multi-organ failure/sepsis, septic shock, candida sepsis, sepsis/cardiogenic shock, Epstein Barr virus reactivation, death of unknown cause."
270,JAKAFI,all-concat,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Symptom Exacerbation Following Interruption or Discontinuation of Treatment with Jakafi, Non-Melanoma Skin Cancer, bruising, dizziness, headache, Urinary Tract Infections, Weight Gain, Flatulence, Herpes Zoster, red blood cell transfusions, Grade 3 or 4 thrombocytopenia, reversible thrombocytopenia, recovery of platelet counts, Platelet transfusions, discontinuation of treatment because of thrombocytopenia, Grade 3 or 4 thrombocytopenia frequency, dose reduction or interruption due to neutropenia, newly occurring or worsening Grade 1 abnormalities in alanine transaminase (ALT), Grade 2 elevations in ALT, newly occurring or worsening Grade 1 abnormalities in aspartate transaminase (AST), Grade 2 AST elevations, newly occurring or worsening Grade 1 elevations in cholesterol, Grade 2 cholesterol elevations, Abdominal Pain, Diarrhea, Fatigue, Pruritus, Dyspnea, Muscle Spasms, Nasopharyngitis, Constipation, Cough, Edema, Arthralgia, Asthenia, Epistaxis, Nausea, Weight gain, hypertension, urinary tract infections, Hypercholesterolemia, Elevated ALT, Elevated AST, Hypertriglyceridemia, Serious bacterial infections, mycobacterial infections, fungal infections, viral infections, Tuberculosis, Progressive multifocal leukoencephalopathy (PML), Herpes Zoster, fever, respiratory distress, hypotension, DIC, multi-organ failure, Non-melanoma skin cancers including basal cell, squamous cell, and Merkel cell carcinoma."
271,JETREA,all-concat,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, Dyschromatopsia, intraocular inflammation, intraocular hemorrhage, lens subluxation, retinal detachment, retinal tear"
272,JUXTAPID,all-concat,"hepatotoxicity, reduced absorption of fat-soluble vitamins, serum fatty acids, gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, decreased weight, fever, back pain, headache, dizziness, pharyngolaryngeal pain, nasal congestion, angina pectoris, palpitations, gastroesophageal reflux disease, defecation urgency, rectal tenesmus, gastroenteritis, transaminase elevations, hepatic steatosis, embryo-fetal toxicity, difficulty controlling INR on warfarin, malabsorption with rare hereditary disorders of galactose intolerance"
273,KADCYLA,all-concat,"Hepatotoxicity, Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Pulmonary Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Hemorrhage, Thrombocytopenia, Neurotoxicity, fatigue, nausea, musculoskeletal pain, headache, increased transaminases, constipation, epistaxis, Neutropenia, Anemia, Lacrimation increased, Dry eye, Vision blurred, Conjunctivitis, Dyspepsia, Stomatitis, Dry Mouth, Abdominal pain, Vomiting, Diarrhea, Peripheral edema, Chills, Pyrexia, Asthenia, Nodular regenerative hyperplasia, Portal hypertension, Drug hypersensitivity, Infusion-related reaction, Urinary tract infection, Blood alkaline phosphatase increased, Hypokalemia, Myalgia, Arthralgia, Dysgeusia, Dizziness, Peripheral neuropathy, Insomnia, Pneumonitis, Dyspnea, Cough, Pruritus, Rash, Hemorrhage, Hypertension, Increased bilirubin, Increased AST, Increased ALT, Decreased platelet count, Decreased hemoglobin, Decreased neutrophils, Decreased potassium, Hepatic failure, anti-therapeutic antibody (ATA) responses, immune response to KADCYLA, serious hepatotoxicity, liver failure, death, reductions in left ventricular ejection fraction (LVEF), embryo-fetal death, birth defects, interstitial lung disease, pneumonitis, acute respiratory distress syndrome, fatal outcome, central nervous system hemorrhage, respiratory hemorrhage, gastrointestinal hemorrhage, decreased platelet count, Grade 3 or 4 peripheral neuropathy, HER2 Testing, Extravasation"
274,KERYDIN,all-concat,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis, skin irritation"
275,KEYTRUDA,all-concat,"immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, renal failure, immune-mediated nephritis, other immune-mediated adverse reactions, infusion-related reactions, fatigue, cough, nausea, pruritus, rash, decreased appetite, constipation, arthralgia, diarrhea, peripheral edema, chills, pyrexia, vomiting, abdominal pain, dyspnea, vitiligo, pain in extremity, myalgia, back pain, headache, dizziness, anemia, insomnia, upper respiratory tract infection, sepsis, hyperglycemia, hyponatremia, hypoalbuminemia, hypertriglyceridemia, increased aspartate aminotransferase, hypocalcemia, hypophysitis, thyroid disorders, hyperthyroidism, hypothyroidism, type 1 diabetes mellitus, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, severe dermatitis including bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis, rigors, wheezing, pruritis, flushing, hypotension, hypoxemia, fever"
276,KIT,all-concat,"injection site irritation, pain, hypersensitivity reactions, serious hypersensitivity reactions, increased risk for cancer"
277,KRYSTEXXA,all-concat,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, congestive heart failure exacerbation, urticaria, dyspnea, chest discomfort, erythema, pruritus, wheezing, peri-oral or lingual edema, hemodynamic instability, rash"
278,KYNAMRO,all-concat,"hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, pain in extremity, musculoskeletal pain, insomnia, hypertension, proteinuria, hypersensitivity reaction with angioedema, glomerular nephritis, thrombocytopenia, idiopathic thrombocytopenic purpura, hepatic enzyme increased, erythema, hematoma, pruritus, swelling, discoloration, recall reactions, myalgia, arthralgia, malaise, anti-KYNAMRO antibodies, liver injury, jaundice, lethargy, alcohol-induced liver injury, hepatotoxic medications interaction, injection site tenderness, injection site swelling"
279,LASTACAFT,all-concat,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence"
280,LATUDA,all-concat,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions Including Stroke, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes (Hyperglycemia and Diabetes Mellitus, Dyslipidemia, Weight Gain), Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Neurological Adverse Reactions in Patients with Parkinson's Disease or Dementia with Lewy Bodies, somnolence, akathisia, extrapyramidal symptoms, nausea, vomiting, diarrhea, anxiety, restlessness, insomnia, agitation, back pain, dizziness, salivary hypersecretion, dyspepsia, nasopharyngitis, influenza, urinary tract infection, increased appetite, fatigue, weight increased, cerebrovascular accident, dysarthria, abnormal dreams, panic attack, sleep disorder, dysuria, renal failure, amenorrhea, dysmenorrhea, breast enlargement, breast pain, galactorrhea, erectile dysfunction, rash, pruritus, angioedema, hypertension, sudden death, rhabdomyolysis, anemia, tachycardia, AV block 1st degree, angina pectoris, bradycardia, vertigo, blurred vision, abdominal pain, gastritis, CPK increased, decreased appetite."
281,LEXISCAN,all-concat,"Myocardial Ischemia, Sinoatrial and Atrioventricular Nodal Block, Atrial Fibrillation/Atrial Flutter, Hypersensitivity Including Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident (Stroke), dyspnea, headache, flushing, chest discomfort, dizziness, angina pectoris, chest pain, nausea, Abdominal Discomfort, Dysgeusia, Feeling Hot, rhythm or conduction abnormalities, PACs, PVCs, First-degree AV block, Second-degree AV block, AV conduction abnormalities, Ventricular conduction abnormalities, Wheezing, FEV1 reduction >15%, Myocardial infarction, cardiac arrest, ventricular arrhythmias, supraventricular tachyarrhythmias, atrial flutter, heart block, asystole, marked hypertension, symptomatic hypotension, transient ischemic attack, seizures, syncope, QTc prolongation, Tremor, transient ischemic attack, cerebrovascular accident, intracranial hemorrhage, Abdominal pain, nausea, vomiting, myalgias, Diarrhea, fecal incontinence, Anaphylaxis, angioedema, cardiac or respiratory arrest, respiratory distress, decreased oxygen saturation, throat tightness, urticaria, rashes, Musculoskeletal pain, Respiratory arrest, dyspnea, wheezing, Fatal cardiac events, sinus bradycardia, first-, second- or third-degree AV block, new-onset or recurrent atrial fibrillation with rapid ventricular response, decreased systolic blood pressure, decreased diastolic blood pressure, convulsive seizures."
282,LINZESS,all-concat,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, gastroesophageal reflux disease, vomiting, fatigue, upper respiratory tract infection, sinusitis, dyspepsia, fecal incontinence, rectal hemorrhage, hematochezia, melena, allergic reactions, urticaria, hives, severe diarrhea, dehydration"
283,LIVALO,all-concat,"Rhabdomyolysis with myoglobinuria and acute renal failure, myopathy (including myositis), Liver Enzyme Abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions including rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, fatal and non-fatal hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment (e.g., memory loss, forgetfulness, amnesia, memory impairment, confusion), immune-mediated necrotizing myopathy (IMNM), increases in serum transaminases (aspartate aminotransferase [AST]/serum glutamic-oxaloacetic transaminase, or alanine aminotransferase [ALT]/serum glutamic-pyruvic transaminase), Increases in HbA1c and fasting serum glucose levels."
284,LUMASON,all-concat,"severe cardiopulmonary reactions, hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope symptoms, anaphylactic shock, dysgeusia, injection site pain, chest discomfort, feeling hot, chest pain, injection site warmth, fatalities, arrhythmias, hypertensive episodes, fatal cardiac or respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, systemic embolization, tissue ischemia, ventricular arrhythmias"
285,LUZU,all-concat,"application site reactions, contact dermatitis, cellulitis"
286,LYNPARZA,all-concat,"Myelodysplastic syndrome/Acute Myeloid Leukemia, Pneumonitis, anemia, nausea, fatigue, asthenia, vomiting, diarrhea, dysgeusia, dyspepsia, headache, decreased appetite, nasopharyngitis, pharyngitis, URI, cough, arthralgia, musculoskeletal pain, myalgia, back pain, dermatitis, rash, abdominal pain, discomfort, increase in creatinine, mean corpuscular volume elevation, decrease in hemoglobin, decrease in lymphocytes, decrease in absolute neutrophil count, decrease in platelets, COPD, cerebrovascular accident, intestinal perforation, pulmonary embolism, sepsis, suture rupture, cough, constipation, peripheral edema, dizziness, urinary tract infection, dyspnea, leukopenia, stomatitis, peripheral neuropathy, pyrexia, hypomagnesemia, hyperglycemia, anxiety, depression, insomnia, dysuria, urinary incontinence, vulvovaginal disorder, dry skin, eczema, pruritis, hypertension, venous thrombosis, hot flush, embryo-fetal toxicity"
287,MEKINIST,all-concat,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, rash, diarrhea, lymphedema, pyrexia, chills, fatigue, nausea, vomiting, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, RPED, RVO, decreased left ventricular ejection fraction (LVEF), pneumonitis, renal failure, stomatitis, xerostomia, folliculitis, rash pustular, cellulitis, rhabdomyolysis, dizziness, dysgeusia, vision blurred, dry eye, bradycardia, increased aspartate aminotransferase (AST), increased alanine aminotransferase (ALT), hypoalbuminemia, anemia, increased alkaline phosphatase, leukopenia, lymphopenia, neutropenia, thrombocytopenia, hyperbilirubinemia, hyperglycemia, increased gamma-glutamyltransferase (GGT), hyponatremia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QTcF prolongation, tumor promotion, hemolytic anemia, basal cell carcinoma, cutaneous squamous cell carcinomas (SCC), keratoacanthoma, new primary melanoma, intracranial hemorrhage, gastric hemorrhage, deep venous thrombosis (DVT), pulmonary embolism (PE), macular edema, neovascularization, glaucoma, retinal pigment epithelial detachment (RPED), uveitis, iritis, serious febrile reactions, fever, hypotension, rigors, dehydration, renal failure, syncope, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, hypertension, transient blindness, pancreatitis, asthenia, skin papilloma, embryotoxic, abortifacient."
288,MOVANTIK,all-concat,"Gastrointestinal perforation, Opioid withdrawal, abdominal pain, diarrhea, nausea, flatulence, vomiting, headache, hyperhidrosis, chills, anxiety, irritability, yawning"
289,MYALEPT,all-concat,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening of metabolic control, increases in HbA1c, increases in triglycerides, excessive weight gain, development of glucose intolerance, diabetes mellitus, T-cell lymphoma, autoimmune disorder progression, hypersensitivity reactions, anaphylaxis, generalized rash, benzyl alcohol toxicity"
290,MYRBETRIQ,all-concat,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, hypertensionIncludes reports of blood pressure above the normal range, and BP increased from baseline, occurring predominantly in subjects with baseline hypertension, constipation, upper respiratory tract infection, arthralgia, abdominal pain, fatigue, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, dizziness, sinusitis, influenza, cystitis, constipation, headache, dizziness, hypertension, dry eyes, nausea, vision blurred, urinary tract infection, cerebrovascular accident, osteoarthritis, serum ALT/AST increased, neoplasm, breast cancer, lung neoplasm malignant, Stevens-Johnson syndrome, angioedema of the face, lips, tongue, and larynx, urinary retention"
291,NATROBA,all-concat,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin, benzyl alcohol toxicity"
292,NPLATE,all-concat,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsening thrombocytopenia after Nplate discontinuation, erythromelalgia, hypersensitivity, angioedema, progression of myelodysplastic syndromes to acute myelogenous leukemia, thrombotic/thromboembolic complications, portal vein thrombosis, bone marrow fibrosis, worsened thrombocytopenia after cessation of Nplate, lack or loss of response to Nplate"
293,NUCYNTA,all-concat,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, and dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, fatigue, feeling hot, nasopharyngitis, upper respiratory tract infection, urinary tract infection, decreased appetite, tremor, lethargy, insomnia, confusional state, abnormal dreams, anxiety, pruritus, hyperhidrosis, pruritus generalized, rash, hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, anaphylaxis, angioedema, anaphylactic shock, Misuse, Abuse and Diversion, Elderly, cachectic, and debilitated patients and patients with chronic pulmonary disease, Interaction with CNS depressants including other opioids, sedatives, alcohol, and illicit drugs, Hypotensive effect, Patients with head injury or increased intracranial pressure, Seizures, Serotonin Syndrome, Withdrawal, Impaired mental/physical abilities, Life Threatening Respiratory Depression, Accidental Exposure, Interactions with Alcohol, Other Opioids, and Drugs of Abuse, Use in Patients with Chronic Pulmonary Disease, Interactions with CNS Depressants and Illicit Drugs, Hypotensive Effect, Use in Patients with Head Injury or Increased Intracranial Pressure, Use in Patients with Gastrointestinal Conditions, Withdrawal, Driving and Operating Heavy Machinery, Hepatic Impairment, Renal Impairment"
294,OFEV,all-concat,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, hypothyroidism, ALT elevations, AST elevations, ALKP elevations, GGT elevations, bilirubin elevations, bleeding events, gastrointestinal perforation"
295,OLYSIO,all-concat,"Serious Symptomatic Bradycardia When Co-administered with Sofosbuvir and Amiodarone, Hepatic Decompensation and Hepatic Failure, Photosensitivity, Rash, rash (including photosensitivity), pruritus, nausea, fatigue, headache, insomnia, dizziness, diarrhea, Myalgia, Dyspnea, Alkaline phosphatase elevation, Hyperbilirubinemia, Serious symptomatic bradycardia, hepatic decompensation, hepatic failure, cardiac arrest, bradycardia, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pain, confusion, memory problems, fatigue, weakness, lack of appetite, nausea and vomiting, jaundice, discolored feces, burning, erythema, exudation, blistering, edema, mucosal signs (e.g., oral lesions, conjunctivitis), systemic symptoms"
296,ONGLYZA,all-concat,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, fractures, thrombocytopenia, idiopathic thrombocytopenic purpura, hypoglycemia, hypersensitivity reactions, urticaria, facial edema, tuberculosis, salmonella sepsis, lymphocyte count decreased, anaphylaxis, angioedema, exfoliative skin conditions, acute pancreatitis, severe and disabling arthralgia"
297,OPDIVO,all-concat,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis and Renal Dysfunction, Immune-Mediated Hypothyroidism and Hyperthyroidism, Other Immune-Mediated Adverse Reactions, rash, fatigue, dyspnea, musculoskeletal pain, decreased appetite, cough, nausea, constipation, abdominal pain, hyponatremia, increased aspartate aminotransferase, increased lipase, pruritus, upper respiratory tract infection, peripheral edema, ventricular arrhythmia, iridocyclitis, infusion-related reactions, increased amylase, dizziness, peripheral and sensory neuropathy, exfoliative dermatitis, erythema multiforme, vitiligo, psoriasis, increased alkaline phosphatase, hyperkalemia, increased ALT, asthenia, edema, pyrexia, chest pain, pain, arthralgia, vomiting, diarrhea, abdominal pain, rash, pruritus, decreased weight, pneumonia, stomatitis, peripheral neuropathy, bronchitis, upper respiratory tract infection, hyponatremia, increased creatinine, hypercalcemia, hypokalemia, hypomagnesemia, hypocalcemia, hyperkalemia, increased AST, increased alkaline phosphatase, increased ALT, lymphopenia, anemia, thrombocytopenia, adrenal insufficiency, uveitis, pancreatitis, facial and abducens nerve paresis, demyelination, autoimmune neuropathy, motor dysfunction, vasculitis, hypophysitis, diabetic ketoacidosis, hypopituitarism, Guillain-Barre syndrome, myasthenic syndrome, embryofetal toxicity"
298,OPSUMIT,all-concat,"Embryo-fetal Toxicity, Hepatotoxicity, Decrease in Hemoglobin, anemia, nasopharyngitis/pharyngitis, bronchitis, headache, influenza, urinary tract infection, hypersensitivity reactions, angioedema, pruritus, rash, nasal congestion, liver failure, elevations of aminotransferases, nausea, vomiting, right upper quadrant pain, fatigue, anorexia, jaundice, dark urine, fever, itching, Pulmonary edema, Pulmonary Veno-occlusive Disease (PVOD), Decreased Sperm Counts"
299,ORBACTIV,all-concat,"hypersensitivity reactions, infusion related reactions, Clostridium difficile-associated diarrhea, osteomyelitis, headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea, serious adverse reactions, cellulitis, discontinued due to adverse reactions, infusion site phlebitis, infusion site reaction, abscess (limb and subcutaneous), alanine aminotransferase increased, aspartate aminotransferase increased, tachycardia, anemia, eosinophilia, infusion site erythema, extravasation, induration, pruritis, rash, edema peripheral, hypersensitivity, infections and infestations, total bilirubin increased, hyperuricemia, hypoglycemia, tenosynovitis, myalgia, bronchospasm, wheezing, urticaria, angioedema, erythema multiforme, leucocytoclastic vasculitis, bleeding, coagulation test interference, aPTT prolongation, PT prolongation, INR prolongation, acute hypersensitivity reaction, pruritus, urticaria, flushing, CDAD, morbidity, mortality, colectomy, fluid and electrolyte management, protein supplementation, surgical evaluation, drug-resistant bacteria."
300,OSPHENA,all-concat,"Cardiovascular Disorders, Malignant Neoplasms, hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), allergic conditions including hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria, endometrial cancer, stroke, coronary heart disease events (defined as nonfatal MI, silent MI, or CHD death), venous thromboembolism (VTE), pulmonary embolism (PE), simple hyperplasia without atypia, endometrial thickening, proliferative endometrium, uterine polyps, breast cancer"
301,PERJETA,all-concat,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions/Anaphylaxis, diarrhea, alopecia, neutropenia, nausea, fatigue, rash, peripheral neuropathy, vomiting, thrombocytopenia, anemia, asthenia, edema peripheral, mucosal inflammation, pyrexia, nail disorder, pruritus, dry skin, constipation, stomatitis, leukopenia, febrile neutropenia, headache, dysgeusia, dizziness, myalgia, arthralgia, upper respiratory tract infection, nasopharyngitis, dyspnea, decreased appetite, lacrimation increased, insomnia, paronychia, pleural effusion, left ventricular dysfunction, hypersensitivity, dizziness, dyspnea, oligohydramnios, delayed renal development, death, cough, epistaxis, oropharyngeal pain, ALT increased, hypokalemia, Palmar-Plantar Erythrodysaesthesia Syndrome, dyspepsia, constipation, cough, epistaxis, oropharyngeal pain, ALT increased"
302,PLEGRIDY,all-concat,"Hepatic Injury, Depression, Suicide, Seizures, Anaphylaxis, Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection site edema, Injection site warmth, Injection site hematoma, Injection site rash, Body temperature increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyl-transferase increased, Pruritus, flu-like symptoms, hepatitis, autoimmune hepatitis, severe hepatic failure, asymptomatic elevation of hepatic transaminases, elevations in hepatic enzymes, elevations of alanine aminotransferase, elevations of aspartate aminotransferase, elevations of serum hepatic transaminases combined with elevated bilirubin, serious allergic reactions, angioedema, urticaria, injection site necrosis, cardiomyopathy, cardiomyopathy with congestive heart failure, cardiovascular events, decreases in white blood cell counts, pancytopenia, severe thrombocytopenia, clinically significant decreases in lymphocyte counts, neutrophil counts, platelet counts, severe neutropenia, idiopathic thrombocytopenia, hyperthyroidism, hypothyroidism, autoimmune hepatitis"
303,POMALYST,all-concat,"Fetal Risk, Venous and Arterial Thromboembolism, Hematologic Toxicity, Hepatotoxicity, Hypersensitivity Reactions, Dizziness and Confusional State, Neuropathy, Risk of Second Primary Malignancies, Tumor Lysis Syndrome, fatigue and asthenia, neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper-respiratory tract infections, back pain, pyrexia, leukopenia, febrile neutropenia, lymphopenia, edema peripheral, chills, vomiting, musculoskeletal chest pain, muscle spasms, arthralgia, muscular weakness, bone pain, musculoskeletal pain, pain in extremity, pneumonia, urinary tract infection, sepsis, decreased appetite, hypercalcemia, hypokalemia, hyperglycemia, hyponatremia, dehydration, hypocalcemia, cough, epistaxis, productive cough, oropharyngeal pain, peripheral neuropathy, headache, tremor, rash, pruritus, dry skin, hyperhidrosis, night sweats, blood creatinine increased, weight decreased, weight increased, anxiety, confusional state, insomnia, renal failure, myocardial infarction, atrial fibrillation, angina pectoris, cardiac failure congestive, vertigo, abdominal pain, general physical health deterioration, non-cardiac chest pain, multi-organ failure, hyperbilirubinemia, Pneumocystis jiroveci pneumonia, respiratory syncytial virus infection, neutropenic sepsis, bacteremia, pneumonia respiratory syncytial viral, cellulitis, urosepsis, septic shock, Clostridium difficile colitis, pneumonia streptococcal, lobar pneumonia, viral infection, lung infection, alanine aminotransferase increased, hemoglobin decreased, fall, compression fracture, spinal compression fracture, hyperkalemia, failure to thrive, depressed level of consciousness, syncope, mental status change, urinary retention, hyponatremia, interstitial lung disease, pulmonary embolism, respiratory failure, bronchospasm, hypotension, Pancytopenia, tumor lysis syndrome, allergic reactions, angioedema, urticaria, elevated liver enzymes, hepatic failure"
304,PREPOPIK,all-concat,"nausea, headache, vomiting, abdominal bloating, distension, pain/cramping, watery diarrhea, electrolyte abnormalities, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, reversible aphthoid ileal ulcers, ischemic colitis, generalized tonic-clonic seizures, rash, urticaria, purpura, orthostatic changes, cardiac arrhythmias, renal impairment, colonic mucosal aphthous ulcerations, dehydration, orthostatic hypotension, significant vomiting, low potassium, low sodium, low chloride, high magnesium, low calcium, high creatinine, low eGFR"
305,RAPIVAB,all-concat,"Serious skin and hypersensitivity reactions, Neuropsychiatric Events, diarrhea, Alanine Aminotransferase (> 2.5 * ULN), Serum Glucose (> 160 mg/dL), Creatine Phosphokinase (>= 6.0 * ULN), Neutrophils (< 1.000 *10^9/L), constipation, insomnia, AST increased, hypertension, Stevens-Johnson Syndrome, exfoliative dermatitis, rash, abnormal behavior, hallucination, erythema multiforme, delirium"
306,RAXIBACUMAB,all-concat,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
307,RELISTOR,all-concat,"Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarctions, Stroke, Cardiac arrest, Sudden death, Cramping, Diaphoresis, Flushing, Malaise, Pain, Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Hyperhidrosis, Chills, Diarrhea, Abdominal pain, Anxiety, Yawning."
308,SABRIL,all-concat,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence and Fatigue, Peripheral Neuropathy, Weight Gain, Edema, permanent vision loss, fatigue, somnolence, nystagmus, tremor, vision blurred, memory impairment, arthralgia, abnormal coordination, confusional state, increased weight, upper respiratory tract infection, aggression, diplopia, bronchitis, ear infection, otitis media acute, headache, dizziness, convulsion, nasopharyngitis, visual field defect, depression, nausea, diarrhea, insomnia, irritability, coordination abnormal, vomiting, influenza, pyrexia, rash, tinnitus, vertigo, asthenopia, eye pain, diarrhoea, constipation, abdominal pain upper, dyspepsia, stomach discomfort, abdominal pain, toothache, abdominal distension, gait disturbance, asthenia, oedema peripheral, fever, chest pain, thirst, malaise, contusion, joint sprain, muscle strain, wound secretion, increased appetite, back pain, pain in extremity, myalgia, muscle twitching, muscle spasms, disturbance in attention, sensory disturbance, hyporeflexia, paraesthesia, lethargy, hyperreflexia, hypoaesthesia, sedation, status epilepticus, dysarthria, postictal state, sensory loss, irritability, anxiety, depressed mood, thinking abnormal, abnormal behaviour, expressive language disorder, nervousness, abnormal dreams, dysmenorrhoea, erectile dysfunction, pharyngolaryngeal pain, cough, pulmonary congestion, sinus headache, strabismus, conjunctivitis, fever, viral infection, pneumonia, candidiasis, gastroenteritis viral, sinusitis, croup infectious, decreased appetite, sedation, status epilepticus, convulsion, hypotonia, irritability, insomnia, nasal congestion, rash, Congenital cardiac defects, congenital external ear anomaly, congenital hemangioma, congenital hydronephrosis, congenital male genital malformation, congenital oral malformation, congenital vesicoureteric reflux, dentofacial anomaly, dysmorphism, fetal anticonvulsant syndrome, hamartomas, hip dysplasia, limb malformation, limb reduction defect, low set ears, renal aplasia, retinitis pigmentosa, supernumerary nipple, talipes, Deafness, Delayed puberty, Gastrointestinal hemorrhage, esophagitis, Developmental delay, facial edema, malignant hyperthermia, multi-organ failure, Cholestasis, Dystonia, encephalopathy, hypertonia, muscle spasticity, myoclonus, optic neuritis, dyskinesia, Acute psychosis, apathy, delirium, hypomania, neonatal agitation, psychotic disorder, Laryngeal edema, pulmonary embolism, respiratory failure, stridor, Angioedema, maculo-papular rash, pruritus, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
309,SAMSCA,all-concat,"thirst, dry mouth, asthenia, constipation, pollakiuria or polyuria, hyperglycemia, pyrexia, anorexia, mortality, nausea, gastrointestinal bleeding, Disseminated intravascular coagulation, Intracardiac thrombus, ventricular fibrillation, Prothrombin time prolonged, Ischemic colitis, Diabetic ketoacidosis, Rhabdomyolysis, Cerebrovascular accident, Urethral hemorrhage, Vaginal hemorrhage, Pulmonary embolism, respiratory failure, Deep vein thrombosis, Osmotic demyelination syndrome, Hypernatremia, Hypersensitivity reactions including anaphylactic shock and rash generalized, dehydration, hypovolemia, liver injury, increased serum potassium"
310,SAVELLA,all-concat,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, upper respiratory tract infection, blood pressure increased, decreased appetite, migraine, paresthesia, tremor, hypoesthesia, tension headache, anxiety, dyspnea, rash, pruritus, flushing, weight loss, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis, suicidality, serotonin syndrome, seizures, hepatotoxicity, withdrawal symptoms, abnormal bleeding, mania, dysuria, angle closure glaucoma, elevated transaminases."
311,SIGNIFOR,all-concat,"Hypocortisolism, Hyperglycemia and Diabetes, Bradycardia and QT prolongation, Liver Test Elevations, Cholelithiasis, Pituitary Hormone Deficiency, diarrhea, nausea, hyperglycemia, cholelithiasis, headache, abdominal pain, fatigue, diabetes mellitus, serious adverse events, adverse events leading to study discontinuation, Diarrhea, Nausea, Hyperglycemia, Cholelithiasis, Headache, Abdominal pain, Fatigue, Diabetes mellitus, Injection site reactions, Nasopharyngitis, Alopecia, Asthenia, Glycosylated hemoglobin increased, Alanine aminotransferase increased, Gamma-glutamyl transferase increased, Edema peripheral, Abdominal pain upper, Decreased appetite, Hypercholesterolemia, Hypertension, Dizziness, Hypoglycemia, Type 2 diabetes mellitus, Anxiety, Influenza, Insomnia, Myalgia, Arthralgia, Pruritus, Lipase increased, Constipation, Hypotension, Vomiting, Back pain, Dry skin, Electrocardiogram QT prolonged, Hypokalemia, Pain in extremity, Sinus bradycardia, Vertigo, Abdominal distension, Adrenal insufficiency, Aspartate aminotransferase increased, Blood glucose increased, anemia, blood amylase increased, prothrombin time prolonged, Gastrointestinal disorders, vomiting, Hypothyroidism, Asymptomatic and reversible elevations in lipase and amylase, Pancreatitis, hemoglobin levels decrease, elevations in PT and PTT, Hypocortisolism, weakness, fatigue, anorexia, nausea, vomiting, hypotension, hyponatremia, hypoglycemia, Hyperglycemia and Diabetes, pre-diabetes, severe hyperglycemia, ketoacidosis, Bradycardia, high-grade heart block, drugs associated with bradycardia, QT Prolongation, congenital long QT prolongation, myocardial infarction, congestive heart failure, unstable angina, clinically significant bradycardia, anti-arrhythmic therapy, substances that lead to QT prolongation, hypokalemia, hypomagnesemia, Liver Test Elevations, ALT or AST level greater than 3 times the upper limit of normal (ULN), concurrent elevations in ALT greater than 3 x ULN and bilirubin greater than 2 x ULN, jaundice, Cholelithiasis, Monitoring for Deficiency of Pituitary Hormones, inhibition of pituitary hormones, TSH/free T4, GH/IGF-1, deficiency of pituitary hormones."
312,SIVEXTRO,all-concat,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, Hemoglobin (<10.1 g/dL [M], <9 g/dL [F]), Platelet count (<112 * 10^3/mm^3), Absolute neutrophil count (<0.8 * 10^3/mm^3), Myelosuppression, Peripheral neuropathy, optic nerve disorders"
313,SOVALDI,all-concat,"Serious Symptomatic Bradycardia When Coadministered with Amiodarone and Another HCV Direct Acting Antiviral, fatigue, headache, nausea, insomnia, anemia, fatigue, headache, nausea, insomnia, anemia, Fatigue, Headache, Nausea, Insomnia, Pruritus, Anemia, Asthenia, Rash, Decreased Appetite, Chills, Influenza Like Illness, Pyrexia, Diarrhea, Neutropenia, Myalgia, Irritability, pancytopenia, severe depression, suicidal ideation, suicide, Hemoglobin <10, Hemoglobin <8.5, Neutrophils >=0.5 - <0.75, Neutrophils <0.5, Platelets >=25 - <50, Platelets <25, Total bilirubin elevation, Creatine Kinase Elevations, Lipase Elevations, Elevated total bilirubin, Serious symptomatic bradycardia, bradycardia, fatal cardiac arrest, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
314,STELARA,all-concat,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome, Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis, Serious infections, Arthralgia, Nausea, Dental infections, Serious bacterial infections, Fungal infections, Viral infections, Diverticulitis, Cellulitis, Pneumonia, Appendicitis, Cholecystitis, Sepsis, Osteomyelitis, Gastroenteritis, Urinary tract infections, Non-melanoma skin cancer, Prostate cancer, Melanoma, Colorectal cancer, Breast cancer, Tuberculosis, Non-tuberculous mycobacteria infections, Salmonella infections, Bacillus Calmette-Guerin (BCG) vaccinations, Multiple cutaneous squamous cell carcinomas, Non-melanoma skin cancer, Rapid appearance of multiple cutaneous squamous cell carcinomas."
315,STIVARGA,all-concat,"Hepatotoxicity, Hemorrhage, Dermatological Toxicity, Hypertension, Cardiac Ischemia and Infarction, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Gastrointestinal Perforation or Fistula, asthenia/fatigue, HFSR, diarrhea, decreased appetite/food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal and abdominal pain, rash, fever, nausea, Hand-foot skin reaction (HFSR), rash, Anemia, Thrombocytopenia, Neutropenia, Lymphopenia, Hypocalcemia, Hypokalemia, Hyponatremia, Hypophosphatemia, Hyperbilirubinemia, Increased AST, Increased ALT, Proteinuria, Increased INR, Increased Lipase, Increased Amylase, Alopecia, Hypothyroidism, Headache, Musculoskeletal stiffness, hypersensitivity reaction, hepatocellular necrosis, severe or life-threatening hemorrhage, erythema multiforme, Stevens Johnson Syndrome, Toxic epidermal necrolysis, hypertensive crisis, myocardial ischemia and infarction, wound dehiscence, embryolethal and teratogenic effects, cardiovascular malformations, genitourinary malformations, skeletal malformations"
316,STRIVERDI,all-concat,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, pneumonia, constipation, pyrexia, lung cancers, paradoxical bronchospasm, cardiovascular effects, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, hypokalemia, hyperglycemia, angioedema"
317,SURFAXIN,all-concat,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, apnea, intraventricular hemorrhage, periventricular leukomalacia, acquired sepsis, patent ductus arteriosus, retinopathy of prematurity, necrotizing enterocolitis, pulmonary air leak, pulmonary interstitial emphysema, pneumothorax, pulmonary hemorrhage, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, hypotension, respiratory acidosis, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, pulmonary embolism"
318,SYLVANT,all-concat,"Concurrent active severe infections, Infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash (rash, rash generalized, rash maculo-papular, rash popular, rash pruritic), Skin hyperpigmentation, Eczema, Psoriasis, Dry skin, Lower respiratory tract infection, Thrombocytopenia, Edema (general and localized), Constipation, Hypertriglyceridemia, Hypercholesterolemia, Oropharyngeal pain, Renal impairment, Headache, Weight increased, Hypotension, Abdominal pain/abdominal distension, Decreased appetite, Dehydration, Edema(peripheral), diarrhea, pain in extremities, arthralgia, fatigue, anaphylactic reaction, back pain, chest pain or discomfort, nausea and vomiting, flushing, erythema, palpitations, Gastrointestinal (GI) perforation"
319,SYNRIBO,all-concat,"myelosuppression, bleeding, hyperglycemia, thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, bone marrow failure, febrile neutropenia, constipation, abdominal pain, upper abdominal pain, vomiting, edema peripheral, leukocytosis, chills, anorexia, arthralgia, pain in extremity, back pain, myalgia, headache, insomnia, cough, epistaxis, alopecia, rash, cerebral hemorrhage, multi-organ failure, progression of disease, leukocytosis, dyspnea, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, ear pain, ear hemorrhage, tinnitus, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension"
320,TRADJENTA,all-concat,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, severe hypoglycemia, acute pancreatitis, fatal pancreatitis, anaphylaxis, exfoliative skin conditions, rash, mouth ulceration, stomatitis, severe and disabling arthralgia, increases in uric acid"
321,VIBATIV,all-concat,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, diarrhea, taste disturbance, nausea, vomiting, foamy urine, death, serious adverse events, renal events, respiratory events, cardiac events, infectious events, treatment discontinuations, rash, pruritus, Rigors, Decreased appetite, renal adverse events, renal impairment, renal insufficiency, renal failure, increased serum creatinine, acute renal failure, electrocardiogram QTc interval prolonged, septic shock, multi-organ failure, Renal Failure Acute, serious hypersensitivity reactions, anaphylactic reactions, hypersensitivity reactions to vancomycin, cross-reactivity to telavancin, ""Red-man Syndrome""-like reactions, flushing of the upper body, urticaria, pruritus, rash, QTc prolongation, drug-resistant bacteria, superinfection, fungi overgrowth, coagulation test interference, prothrombin time, international normalized ratio, activated partial thromboplastin time, activated clotting time, coagulation based factor X activity assay, adverse developmental outcomes in humans, decreased clinical response, decreased efficacy."
322,VICTOZA,all-concat,"Risk of Thyroid C-cell Tumors, Pancreatitis, Use with Medications Known to Cause Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, headache, nausea, diarrhea, anti-liraglutide antibody formation, Immunogenicity-related events, urticaria, Withdrawals, gastrointestinal adverse reactions, nausea, vomiting, dyspepsia, constipation, upper respiratory tract infections, Injection site reactions, injection site rash, erythema, Papillary thyroid carcinoma, Hypoglycemia, Medullary thyroid carcinoma, Dehydration, Increased serum creatinine, acute renal failure, worsening of chronic renal failure, Angioedema, anaphylactic reactions, Allergic reactions, rash, pruritus, Acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, malignant neoplasms, mildly elevated serum bilirubin concentrations, elevated serum calcitonin, increase in pulse rate"
323,VIEKIRA,all-concat,"Increased Risk of ALT Elevations, fatigue, nausea, pruritus, other skin reactions, insomnia, asthenia, serious adverse event (SAE), rash, erythema, eczema, rash maculo-papular, rash macular, dermatitis, rash papular, skin exfoliation, rash pruritic, rash erythematous, rash generalized, dermatitis allergic, dermatitis contact, exfoliative rash, photosensitivity reaction, psoriasis, skin reaction, ulcer, urticaria, dyspnea, serum ALT levels greater than 5 times the upper limit of normal (ULN), clinically relevant ALT elevations, drug-related liver injury, bilirubin elevations, indirect bilirubin increases, ribavirin-induced hemolysis, anemia, decreased hemoglobin, headache, cough, irritability, ocular icterus, hyperbilirubinemia, diarrhea, muscle spasms, hypersensitivity reactions, angioedema, loss of therapeutic effect of VIEKIRA PAK, clinically significant adverse reactions from greater exposures of concomitant drugs or components of VIEKIRA PAK, HIV-1 protease inhibitor drug resistance."
324,VIIBRYD,all-concat,"Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, nausea (1.4%), Diarrhea, Nausea, Dry mouth, Vomiting, Abdominal pain, Dyspepsia, Flatulence, Gastroenteritis, Abdominal distension, Headache, Dizziness, Somnolence, Paresthesia, Insomnia, Abnormal dreams, Restlessness, Fatigue, Palpitations, Increased appetite, Arthralgia, Increased weight, Abnormal Orgasm, Erectile dysfunction, Libido decreased, Ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt, suicidal ideation, rash, generalized rash, urticaria, drug eruption, agitation, delirium, coma, tachycardia, labile blood pressure, diaphoresis, flushing, hyperthermia, rigidity, myoclonus, hyperreflexia, incoordination, serotonin syndrome signs and symptoms, gastrointestinal bleeding, ecchymosis, hematoma, epistaxis, petechiae, life-threatening hemorrhages, dysphoric mood, irritability, agitation, sensory disturbances, electric shock sensations, anxiety, confusion, headache, lethargy, emotional lability, hypomania, tinnitus, seizures, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, syndrome of inappropriate antidiuretic hormone secretion (SIADH)."
325,VIMPAT,all-concat,"Suicidal Behavior and Ideation, Dizziness, Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, diplopia, headache, nausea, insomnia, somnolence, fatigue, vomiting, blurred vision, vertigo, diarrhea, gait disturbance, asthenia, contusion, skin laceration, tremor, nystagmus, balance disorder, memory impairment, depression, pruritus, neutropenia, anemia, palpitations, tinnitus, constipation, dyspepsia, dry mouth, oral hypoaesthesia, irritability, pyrexia, feeling drunk, fall, muscle spasms, paresthesia, cognitive disorder, hypoaesthesia, dysarthria, disturbance in attention, cerebellar syndrome, confusional state, mood altered, depressed mood, injection site pain or discomfort, irritation, erythema, profound bradycardia, agranulocytosis, aggression, agitation, hallucination, psychotic disorder, angioedema, rash, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, PR interval prolongation, first-degree atrioventricular block, second degree AV block, complete AV block, atrial fibrillation, atrial flutter, withdrawal of Antiepileptic Drugs (AEDs), hepatitis, nephritis, lymphadenopathy, myocarditis, phenylketonurics."
326,VOTRIENT,all-concat,"diarrhea, hypertension, hair color changes (depigmentation), nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial and venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation and fistula, interstitial lung disease (ILD)/pneumonitis, reversible posterior leukoencephalopathy syndrome (RPLS), infection, increased toxicity with other cancer therapies, asthenia, abdominal pain, alopecia, chest pain, dysphonia, facial edema, palmar-plantar erythrodysesthesia (hand-foot syndrome), proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, skin hypopigmentation, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dry skin, chills, vision blurred, nail disorder, lipase elevations, pneumothorax, bradycardia, retinal detachment/tear, pancreatitis, severe and fatal hepatotoxicity, increases in serum transaminase levels and bilirubin, prolonged QT intervals, congestive heart failure, decreased left ventricular ejection fraction (LVEF), fatal hemorrhagic events, myocardial infarction or ischemia, cerebrovascular accident, transient ischemic attack, myocardial dysfunction, hematuria, epistaxis, hemoptysis, rectal hemorrhage, cerebral/intracranial hemorrhage, mouth hemorrhage, anal hemorrhage, intracranial hemorrhage, subarachnoid hemorrhage, peritoneal hemorrhage, myocardial infarction, ischemia, cerebrovascular accident, pulmonary embolus (PE), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), wound dehiscence, nephrotic syndrome, serious infections (with or without neutropenia), pulmonary hemorrhage, gastrointestinal hemorrhage, sudden death, effects on organ growth and maturation, teratogenic effects, embryotoxic effects, fetotoxic effects, abortifacient effects."
327,VPRIV,all-concat,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue/asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension, chest discomfort, dyspnea, pruritus, anaphylaxis"
328,XARELTO,all-concat,"Increased risk of stroke after discontinuation in nonvalvular atrial fibrillation, Bleeding risk, Spinal/epidural hematoma, bleeding, Hemorrhage, Major bleeding, Bleeding into a critical organ, Fatal bleeding, Bleeding resulting in transfusion of >=2 units of whole blood or packed red blood cells, Gastrointestinal bleeding, Intracranial, Non-fatal critical organ bleeding, Retroperitoneal, Intraocular, Intra-articular, Non-fatal non-critical organ bleeding, Decrease in Hb >= 2g/dL, Transfusion of >=2 units of whole blood or packed red blood cells, Clinically relevant non-major bleeding, Any bleeding, Menorrhagia, Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery, Major bleeding event, Bleeding that required re-operation, Extra-surgical site bleeding requiring transfusion of >2 units of whole blood or packed cells, Any bleeding event, Wound secretion, Pain in extremity, Muscle spasm, Syncope, Pruritus, Blister, pulmonary hemorrhage, pulmonary hemorrhage with bronchiectasis, agranulocytosis, thrombocytopenia, retroperitoneal hemorrhage, jaundice, cholestasis, hepatitis, hepatocellular injury, hypersensitivity, anaphylactic reaction, anaphylactic shock, angioedema, cerebral hemorrhage, subdural hematoma, epidural hematoma, hemiparesis, Stevens-Johnson syndrome, thrombotic events, Risk of bleeding, Pregnancy-related hemorrhage, Risk of Pregnancy-Related Hemorrhage, Acute PE in Hemodynamically Unstable Patients or Patients Who Require Thrombolysis or Pulmonary Embolectomy."
329,XELJANZ,all-concat,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, infections, urinary tract infections, pneumonia, cellulitis, herpes zoster, urinary tract infection, tuberculosis, opportunistic infections, malignancies, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, liver injury, lipid elevations, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema, gastrointestinal perforations, lymphocyte abnormalities, neutrophil abnormalities, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder"
330,XENAZINE,all-concat,"Depression, suicidality, Akathisia, restlessness, agitation, Parkinsonism, Dysphagia, Sedation, somnolence, fatigue, insomnia, anxiety, nausea, irritability, decreased appetite, obsessive reaction, balance difficulty, dizziness, dysarthria, unsteady gait, headache, vomiting, fall, laceration (head), ecchymosis, upper respiratory tract infection, shortness of breath, bronchitis, dysuria, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash, worsening mood, cognition, rigidity, functional capacity, suicidal thoughts, behavior, unusual changes in behavior, Neuroleptic Malignant Syndrome (NMS), hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, tachycardia, diaphoresis, cardiac dysrhythmia, elevated creatinine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, QTc prolongation, torsade de pointes-type ventricular tachycardia, hypotension, orthostatic hypotension, postural dizziness, syncope, Hyperprolactinemia, amenorrhea, galactorrhea, gynecomastia, impotence, Tardive Dyskinesia (TD), involuntary, dyskinetic movements, ophthalmologic effects."
331,XOFIGO,all-concat,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, Pancytopenia, Renal failure and impairment, Dehydration, Erythema, pain, edema at the injection site, Secondary Malignant Neoplasms, osteosarcoma, bone marrow failure, vascular hemorrhage, infection-related deaths, serious infections, febrile neutropenia"
332,ZALTRAP,all-concat,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia and Neutropenic Complications, Diarrhea and Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), leukopenia, diarrhea, neutropenia, proteinuria, AST increased, stomatitis, fatigue, thrombocytopenia, ALT increased, weight decreased, decreased appetite, epistaxis, abdominal pain, dysphonia, serum creatinine increased, headache, Urinary Tract Infection, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Vascular disorders, Respiratory, thoracic and mediastinal disorders, Gastrointestinal disorders, Skin and subcutaneous tissue disorders, Renal and urinary disorders, General disorders and administration site conditions, Investigations, severe hypersensitivity reactions, venous thromboembolic events (VTE), deep venous thrombosis, pulmonary embolism, Immunogenicity, bleeding/hemorrhage, hematuria, post-procedural hemorrhage, intracranial hemorrhage, pulmonary hemorrhage/hemoptysis, GI perforation, compromised wound healing, fistulas (anal, enterovesical, enterocutaneous, colovaginal, intestinal sites), Grade 3 GI fistula formation, Grade 3-4 hypertension, hypertensive crisis, hypertensive encephalopathy, transient ischemic attack, cerebrovascular accident, angina pectoris, nephrotic syndrome, thrombotic microangiopathy (TMA), febrile neutropenia, neutropenic infection/sepsis, dehydration, RPLS, posterior reversible encephalopathy syndrome."
333,ZELBORAF,all-concat,"New Primary Malignancies, Hypersensitivity Reactions, Dermatologic Reactions, QT Prolongation, Hepatotoxicity, Photosensitivity, Ophthalmologic Reactions, Radiation Sensitization and Radiation Recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, Grade 3 adverse reactions, Grade 4 adverse reactions, permanent discontinuation of study medication, Skin and subcutaneous tissue disorders, Rash, Photosensitivity reaction, Alopecia, Pruritus, Hyperkeratosis, Rash maculo-papular, Actinic keratosis, Dry skin, Rash papular, Erythema, Musculoskeletal and connective tissue disorders, Arthralgia, Myalgia, Pain in extremity, Musculoskeletal pain, Back pain, General disorders and administration site conditions, Fatigue, Edema peripheral, Pyrexia, Asthenia, Gastrointestinal disorders, Nausea, Diarrhea, Vomiting, Constipation, Nervous system disorders, Headache, Dysgeusia, Neoplasms benign, malignant and unspecified (includes cysts and polyps), Skin papilloma, Cutaneous SCC, Seborrheic keratosis, Investigations, Gamma-glutamyltransferase increased, Metabolism and nutrition disorders, Decreased appetite, Respiratory, thoracic and mediastinal disorders, Cough, Injury, poisoning and procedural complications, Sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, GGT, AST, ALT, Alkaline phosphatase, Bilirubin, Progression of pre-existing chronic myelomonocytic leukemia with NRAS mutation, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Neutropenia, Radiation sensitization and recall, Pancreatitis, Cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, Non-Cutaneous Squamous Cell Carcinoma, Other Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Serious Hypersensitivity Reactions including anaphylaxis and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome), Severe Dermatologic Reactions, including Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, QT Prolongation, Hepatotoxicity, Photosensitivity, Serious Ophthalmologic Reactions, Embryo-Fetal Toxicity, Radiation Sensitization and Radiation Recall."
334,ZIOPTAN,all-concat,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus including allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis/uveitis, deepening of the eyelid sulcus, increased pigmentation of the iris, increased pigmentation of the periorbital tissue, increased pigmentation of the eyelashes, iris color change, intraocular inflammation, macular edema, cystoid macular edema"
335,ZONTIVITY,all-concat,"Bleeding, life-threatening bleeding, fatal bleeding, GUSTO severe bleeding, GUSTO moderate bleeding, bleeding with hemodynamic compromise requiring intervention, bleeding requiring transfusion of whole blood or packed red blood cells, GUSTO moderate or severe bleeding, Non-CABG-Related Bleeds, Fatal Bleeding, Intracranial Hemorrhage (ICH), Clinically Significant Bleeding, Gastrointestinal Bleeding, Anemia, Depression, Rashes, Eruptions, and Exanthemas, iron deficiency, retinopathy or retinal disorder, diplopia/oculomotor disturbances, increased risk of bleeding, including ICH and fatal bleeding, risk of bleeding, underlying risk of bleeding, history of bleeding disorders, hypotensive, suspect bleeding, antiplatelet effect, Significant inhibition of platelet aggregation"
